Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 50(2); 2018 > Article
Special Article Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
Kyu-Won Jung, MS1,2, Young-Joo Won, PhD1,2,3,, Hyun-Joo Kong, MS1,2, Eun Sook Lee, MD, PhD1,4, The Community of Population-Based Regional Cancer Registries,*
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2018;50(2):303-316.
DOI: https://doi.org/10.4143/crt.2018.143
Published online: March 21, 2018

1The Korea Central Cancer Registry, National Cancer Center, Goyang, Korea

2National Cancer Control Institute, National Cancer Center, Goyang, Korea

3Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

4National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

Correspondence: Young-Joo Won, PhD The Korea Central Cancer Registry, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea
Tel: 82-31-920-2015 Fax: 82-31-920-2179 E-mail: astra67@ncc.re.kr
*The members of the group are listed at the end of this article.
• Received: March 6, 2018   • Accepted: March 21, 2018

Copyright © 2018 by the Korean Cancer Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 35,093 Views
  • 1,367 Download
  • 309 Web of Science
  • 318 Crossref
  • 322 Scopus
next
  • Purpose
    This study presents the 2015 nationwide cancer statistics in Korea, including the incidence, survival, prevalence, and mortality.
  • Materials and Methods
    Cancer incidence data from 1999 to 2015 was obtained from the Korea National Cancer Incidence Database and followed until December 31, 2016. Mortality data from 1983 to 2015 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January 1, 2016, among all cancer patients diagnosed since 1999. Crude and age-standardized rates (ASRs) for incidence, mortality and prevalence and 5-year relative survivals were also calculated.
  • Results
    Herein, 214,701 and 76,855 Koreans were newly diagnosed and died from cancer in 2015, respectively. The ASRs for cancer incidence and mortality in 2015 were 258.9 and 82.0 per 100,000, respectively. The overall cancer incidence rate has increased significantly by 3.4% annually from 1999 to 2012, and started to decrease after 2012 (2012-2015, annual percent change, –6.1%). However, the overall cancer mortality has decreased 2.7% annually since 2002. The 5-year relative survival rate for patients diagnosed with cancer between 2011 and 2015 was 70.7%, an improvement from the 41.2% for patients diagnosed between 1993 and 1995.
  • Conclusion
    Age-standardized cancer incidence rates have decreased since 2012 and mortality rates have declined since 2002; however, the 5-year survival rates have improved remarkably from 1993-1995 to 2011-2015 in Korea.
Cancer is a major life-threatening disease worldwide. Approximately 14.1 million patients were newly diagnosed with cancer and 8.2 million people died from cancer in 2012 worldwide [1]. The global burden of cancer is expected to grow rapidly due to aging population [2].
In Korea, cancer accounts for one in four deaths and more than 200,000 new cancer cases were diagnosed in 2014 [3]. The number of cancer incidences and deaths are expected to increase with the aging population and westernized lifestyles [4]. Additionally, the economic burden of cancer in Korea increased approximately 1.8-fold, from $11,424 to $20,858 million, between 2000 and 2010 [5].
In this context, cancer statistics are the most important indicator of the national cancer burden and can be used to form cancer prevention and control strategies. This study aims to provide nationwide cancer statistics including the incidence, survival, prevalence, and mortality in 2015.
1. Data sources
The Korea Central Cancer Registry (KCCR) was established by the Ministry of Health and Welfare in 1980 as a nationwide hospital-based cancer registry. Since 1999, the KCCR has collected cancer incidence data for the entire nation by compiling a nationwide hospital-based KCCR database that contains data from regional cancer registry programs. The KCCR currently provides the nationwide cancer incidence, survival, and prevalence statistics annually [6].
The KCCR constructed the Korea National Cancer Incidence Database (KNCI DB) using hospitals data, 11 population-based registries, and additional medical chart reviews. The KNCI DB contains information regarding the age, sex, address, date of diagnosis, primary cancer site, histological type, most valid diagnostic method, and Surveillance, Epidemiology, and End Results (SEER) stage. The completeness of cancer incidence data for 2015 was estimated to be 98.2% based on the method proposed by Ajiki et al. [7]. The mid-year population and cancer mortality data from 1983 to 2015 were obtained from Statistics Korea [8]. To ascertain vital status and to calculate survival and prevalence, the KNCI DB was linked to the mortality data and population registration data established by the Ministry of the Interior and Safety.
2. Classification
All incident cases were registered according to the International Classification of Diseases for Oncology, third edition [9], and converted to the International Classification of Diseases, 10th edition (ICD-10) codes [10]. The mortality cases were registered according to ICD-10 codes. All cancer cases were reported based on the 24 cancer types.
3. Statistical analyses
Rates were expressed as crude and age-standardized rates (CR and ASR, respectively) per 100,000 individuals. The CR was calculated as the total number of incidence/mortality cases divided by the mid-year population for the specified years. The ASR is a weighted average of the age-specific rates, where the weights are the proportions of persons in the corresponding age groups of a standard population [11]. In this report, ASRs were calculated using Segi’s world standard population [12]. The cumulative risk of developing cancer from birth to life expectancy was calculated using cumulative rates; that is, the sum of the age-specific rates from birth to life expectancy, as follows [13]:
Cumulative risk of developing cancer from birth to life expectancy=100×(1-ecumulative rate100)
Trends in incidence/mortality rates were summarized as an annual percentage change (APC) by using a Joinpoint regression. APC is the average percentage change of rates and is calculated as follows [11]:
APC=Ry+1-RyRy×100=(eb1-1)×100
, where log(Ry)=b0+b1y,
log(Ry) is the natural log transformed age standardized rates.
y=year, b0=intercept, b1=slope
The survival duration for each cancer case was calculated as the interval between the date of the initial diagnosis and the date of death, date of loss to follow-up, or closing date for follow-up. The 5-year relative survival rates (RSRs) were calculated as the ratios of the observed survival of the cancer patients to the expected survival of the general population, which was derived from the standard life table provided by Statistics Korea. Trends in 5-year RSRs were evaluated as percentage differences in 5-year RSRs from 1993-1995 and 2011-2015. RSRs were calculated using the Ederer II method [14] with some minor corrections, based on an algorithm established by Paul Dickman [15].
Prevalent cases were defined as the number of cancer patients alive on January 1, 2016 among all cancer patients diagnosed between 1999 and 2015. Limited-duration prevalences were calculated using SEER*Stat software. Any p-values less than 0.05 were considered statistically significant. SEER*Stat 8.2.1 (National Cancer Institute, Bethesda, MD), Joinpoint 4.1.1 (National Cancer Institute), and SAS 9.4 (SAS Institute Inc., Cary, NC) were used in this report.
1. Incidence
A total of 214,701 cases were newly diagnosed with cancer during 2015 (Table 1). Of these cases, 113,335 (52.8%) were men and 101,366 (47.2%) were women. Stomach cancer was the most commonly diagnosed cancer in 2015, followed by colorectal, thyroid, lung, and breast cancer. The overall cumulative risk of developing cancer from birth to life expectancy was 35.3%. However, the cumulative risk of developing cancer from birth to life expectancy was higher in men (37.9%) than in women (32.0%) (data not shown).
The total CR and ASR for the overall cancer incidences in 2015 were 421.4 and 258.9 per 100,000, respectively (Table 2). According to sex, the CRs for all sites combined were 445.2 in men and 397.6 in women. The ASRs were 291.7 and 241.1 in men and women, respectively. Stomach cancer (CR, 76.8) was the most common cancer in men, followed by lung (CR, 66.8), colorectal (CR, 62.5), liver (CR, 46.1), and prostate cancer (CR, 40.1). These five cancers accounted for 65.7% of the newly diagnosed cases in men during the study period. In contrast, thyroid cancer (CR, 77.1) was the most common cancer among women, followed by breast (CR, 75.1), colorectal (CR, 42.7), stomach (CR, 37.9), and lung cancer (CR, 28.4), which five cancers accounted for 65.7% of the cases in women.
2. Mortality
In 2015, the total number of deaths from cancer was 76,855, accounting for 27.9% of all deaths (Table 3). In terms of sex, 62.0% and 38.0% of cancer deaths occurred in men and women, respectively (Table 1).
The total CR and ASR for cancer deaths were 150.8 and 82.0 per 100,000, respectively, in 2015 (Table 4). The total CR and ASR for cancer deaths per 100,000 were higher among men (CR, 187.3; ASR, 119.6) than among women (CR, 114.4; ASR, 54.6).
According to cancer sites, lung cancer (CR, 49.8) was the leading cause of death in men, followed by liver (CR, 32.9), stomach (CR, 21.6), colorectal (CR, 18.5), and pancreatic cancer (CR, 11.4). The top five causes of deaths from cancer in women included lung (CR, 18.5), colorectal (CR, 14.1), stomach (CR, 11.8), liver (CR, 11.5), and pancreatic cancer (CR, 9.9).
3. Trends in cancer incidence and mortality
Fig. 1 shows the trends in cancer incidence and mortality from 1983 to 2015. The ASR for all-cancer incidence increased by 3.4% annually from 1999 to 2012, and then began to decrease from 2012 to 2015 (APC, –6.1%) (Table 5, Fig. 1). The incidence of cancers in stomach, colorectum, lung and thyroid started to decrease around 2011. Especially, the ASR for thyroid cancer has increased rapidly 22.8% from 1999 to 2011, but then decreased swiftly 13.3% annually starting in 2011. Incidence of breast cancer has increased constantly throughout the period, but the APC slowly started to decrease since 2007. Conversely, the incidence rates of cervix and liver showed a constant decrease for the whole period. The incidence of liver cancer decreased drastically starting in 2010 (Fig. 2).
The ASR for the all-cancer mortality rate has been increased until 2002 (Table 6, Fig. 1). After that year, it began to decrease (2002-2015, APC, –2.7%). Similar patterns were observed in men and women. According to cancer sites, the mortality rates for most cancers including those of the lung, liver, colorectum, gallbladder, leukemia, brain and central nervous system, cervix uteri, and thyroid started to decrease in the early 2000s. However, the mortality rates for cancers of the stomach, larynx, testis, bladder, and non-Hodgkin lymphoma decreased starting in 1999 (Fig. 3). Cancers in the pancreas, breast, and prostate showed constant increasing trends for the whole period.
4. Age-specific incidence
Leukemia was the most commonly diagnosed cancer among children aged 0-14 years (Table 7). Thyroid cancer was the most common cancer among adolescents and young adults between 15 and 34 years of age. For men, the incidence rate of cancer increased before age 70 years (Fig. 4A). Stomach cancer was the most commonly diagnosed cancer among men aged 35 to 64 years, while lung cancer was the most common among men aged ≥ 65 years. In contrast, breast cancer was most commonly diagnosed among women aged 35-64 years, while colorectal cancer was the most common among women aged ≥ 65 years. The incidence rates for thyroid and breast cancer showed an inverted U-shaped pattern when analyzed according to age (Fig. 4B).
5. Survival rates
The 5-year RSRs for all cancer combined improved remarkably in both sexes, from 41.2% in 1993-1995 to 70.7% in 2011-2015 (Table 8, Fig. 5A). After excluding thyroid cancer, the 5-year RSRs for all cancer still increased from 1993 to 2015 (Fig. 5B).
The 5-year RSR during 2011-2015 for all cancers combined was 62.8% in men and 78.4% in women, respectively. The 5-year RSR for thyroid cancer was over 100%, while the 5-year RSRs for testis, prostate, and breast cancer were over 90% in 2011-2015 for both sexes. However, the 5-year RSR for pancreatic cancer was only 10.8% in both sexes in 2011-2015.
When compared to the 5-year RSR for men in 1993-1995, prostate cancer diagnosed from 2011 to 2015 showed the most outstanding improvement, followed by stomach, leukemia, “lip, oral cavity and pharynx” and liver cancer. Among women, stomach cancer diagnosed during 2011-2015 showed the greatest improvement in 5-year RSRs compared to those between 1993 and 1995, followed by leukemia, lung, colorectal, and kidney cancer.
6. Prevalence
A total of 1,611,487 prevalent cancer cases were identified on January 1, 2016 (Table 1). Of these cases, 707,977 (43.9%) were men and 903,510 (56.1%) were women. The crude and age-standardized prevalence rates for overall cancer were 3,162.8 per 100,000 individuals and 1,956.9 per 100,000 individuals for both sexes, respectively, in 2015 (Table 9).
The five most common cancers for men were stomach (CR, 668.9), colorectal (CR, 516.8), prostate (CR, 272.8), thyroid (CR, 236.3), and liver cancer (CR, 180.2). In contrast, thyroid cancer was most common in women (CR, 1156.8), followed by breast (CR, 699.8), colorectal (CR, 349.4), stomach (CR, 340.1), and cervix uteri cancer (CR, 198.0).
Analysis of the period after cancer diagnosis revealed that thyroid (15.8%) cancer was the most prevalent cancer within 2 years after diagnosis, followed by stomach (14.3%) and colorectal cancer (13.2%) (Fig. 6). Thyroid cancer (27.4%) was most prevalent for 2-5 years, followed by stomach (14.5%) and colorectal cancer (13.6%). After 5 years, thyroid cancer (21.7%) was the most prevalent cancer, followed by stomach (17.6%) and colorectal cancer (14.0%).

Conflict of interest relevant to this article was not reported.

Acknowledgements
This work was supported by a research grant from the National Cancer Center (No. 1610200), Republic of Korea. The authors are indebted to the Korea Central Cancer Registry (KCCR)-affiliated hospitals, non-KCCR-affiliated hospitals, the National Health Insurance Service and Statistics Korea for the data collection.

The Community of Population-Based Regional Cancer Registries

Chang-Hoon Kim (Busan Cancer Registry, Pusan National University Hospital), Cheol-In Yoo (Ulsan Caner Registry, Ulsan University Hospital), Jong-Hyock Park (Chungbuk Cancer Registry, Chungbuk National University Hospital), Hae-Sung Nam (Daejeon/Chungnam Cancer Registry, Chungnam National University and Hospital), Jung-Sik Huh (Jeju Cancer Registry, Jeju National University and Hospital), Jung-Ho Youm (Chonbuk Cancer Registry, Chonbuk National University Hospital), Eurah Goh (Kangwon Cancer Registry, Kangwon National University Hospital), Nam-Soo Hong (Daegu/Gyeongbuk Cancer Registry, Kyungpook National University Medical Center), Sun-Seog Kweon (Gwangju/Jeonnam Cancer Registry, Chonnam National University Hospital), Woo-Chul Kim (Incheon Cancer Registry, Inha University Hospital), Yune-Sik Kang (Gyeongnam Cancer Registry, Gyeongsang National University & Hospital)

Fig. 1.
Annual age-standardized cancer incidence and death rates by sex for all sites from 1983 to 2015 in Korea. Age standardization was based on the Segi’s world standard population.
crt-2018-143f1.gif
Fig. 2.
Trends in age-standardized incidences of selected cancers by sex from 1999 to 2015 in Korea. Age standardization was based on the Segi’s world standard population. (A) Men. (B) Women.
crt-2018-143f2.gif
Fig. 3.
Annual age-standardized cancer mortalities of selected cancers by sex from 1983 to 2015 in Korea. (A) Men. (B) Women. Age-standardization was based on the Segi’s world standard population.
crt-2018-143f3.gif
Fig. 4.
Age-specific incidence rates of common cancers for 2015 in Korea. (A) Men. (B) Women.
crt-2018-143f4.gif
Fig. 5.
Trends in relative survival by year of diagnosis from 1999 to 2014. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.
crt-2018-143f5.gif
Fig. 6.
Prevalence of common cancer sites by time period after cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2016 among all cancer patients diagnosed between 1999 and 2015.
crt-2018-143f6.gif
Table 1.
Cancer incidence, deaths and prevalence by sex in Korea, 2015
Site/Type New cases
Deaths
Prevalent casesa)
Both sexes Men Women Both sexes Men Women Both sexes Men Women
All sites 214,701 113,335 101,366 76,855 47,678 29,177 1,611,487 707,977 903,510
Lip, oral cavity, and pharynx 3,309 2,390 919 1,170 884 286 21,827 14,656 7,171
Esophagus 2,420 2,201 219 1,531 1,401 130 9,171 8,262 909
Stomach 29,207 19,545 9,662 8,526 5,507 3,019 256,995 170,294 86,701
Colon and rectum 26,790 15,911 10,879 8,301 4,698 3,603 220,653 131,579 89,074
Liver 15,757 11,732 4,025 11,311 8,382 2,929 61,290 45,881 15,409
Gallbladderb) 6,251 3,220 3,031 4,211 2,135 2,076 19,468 9,958 9,510
Pancreas 6,342 3,359 2,983 5,439 2,908 2,531 9,517 5,031 4,486
Larynx 1,146 1,079 67 344 319 25 10,049 9,452 597
Lung 24,267 17,015 7,252 17,399 12,677 4,722 69,931 43,987 25,944
Breast 19,219 77 19,142 2,354 16 2,338 179,081 686 178,395
Cervix uteri 3,582 - 3,582 967 - 3,582 50,477 - 3,582
Corpus uteri 2,404 - 2,404 319 - 2,404 20,859 - 2,404
Ovary 2,443 - 2,443 1,055 - 2,443 18,112 - 2,443
Prostate 10,212 10,212 - 1,700 1,700 - 69,438 69,438 -
Testis 286 286 - 10 10 - 2,939 2,939 -
Kidney 4,555 3,134 1,421 952 672 280 35,333 23,862 11,471
Bladder 4,033 3,245 788 1,299 960 339 31,407 25,609 5,798
Brain and CNS 1,776 958 818 1,266 674 592 10,349 5,334 5,015
Thyroid 25,029 5,386 19,643 341 106 235 355,057 60,151 294,906
Hodgkin lymphoma 271 174 97 49 33 16 2,571 1,623 948
Non-Hodgkin lymphoma 4,396 2,519 1,877 1,771 1,026 745 27,478 15,622 11,856
Multiple myeloma 1,455 762 693 889 466 423 5,330 2,779 2,551
Leukemia 3,242 1,830 1,412 1,720 1,003 717 19,260 10,654 8,606
Other and ill defined 16,309 8,300 8,009 3,931 2,101 1,830 104,895 50,180 54,715

CNS, central nervous system.

a) Limited-duration prevalent cases on January 1, 2016. These are patients who were diagnosed between January 1, 1999 and December 31, 2015 and who were alive on January 1, 2016. Multiple primary cancer cases were counted multiple times,

b) Include the gallbladder and other/unspecified parts of the biliary tract.

Table 2.
Crude and age-standardized cancer incidence rates by sex in Korea, 2015
Site/Type Crude incidence rate per 100,000
Age-standardized incidence rate per 100,000a)
Both sexes Men Women Both sexes Men Women
All sites 421.4 445.2 397.6 258.9 291.7 241.1
Lip, oral cavity, and pharynx 6.5 9.4 3.6 4.1 6.2 2.2
Esophagus 4.7 8.6 0.9 2.7 5.5 0.4
Stomach 57.3 76.8 37.9 33.8 49.3 20.5
Colon and rectum 52.6 62.5 42.7 30.4 40.2 22.2
Liver 30.9 46.1 15.8 18.2 29.5 8.2
Gallbladderb) 12.3 12.6 11.9 6.6 8.0 5.5
Pancreas 12.4 13.2 11.7 7.0 8.5 5.7
Larynx 2.2 4.2 0.3 1.3 2.7 0.1
Lung 47.6 66.8 28.4 26.4 42.3 14.3
Breast 37.7 0.3 75.1 24.8 0.2 49.2
Cervix uteri 7.0 - 14.1 4.6 - 9.1
Corpus uteri 4.7 - 9.4 3.1 - 6.1
Ovary 4.8 - 9.6 3.2 - 6.3
Prostate 20.0 40.1 - 11.2 25.4 -
Testis 0.6 1.1 - 0.6 1.1 -
Kidney 8.9 12.3 5.6 5.7 8.2 3.4
Bladder 7.9 12.7 3.1 4.3 8.1 1.5
Brain and CNS 3.5 3.8 3.2 2.8 3.1 2.4
Thyroid 49.1 21.2 77.1 35.2 15.1 55.6
Hodgkin lymphoma 0.5 0.7 0.4 0.5 0.6 0.4
Non-Hodgkin lymphoma 8.6 9.9 7.4 5.9 7.2 4.6
Multiple myeloma 2.9 3.0 2.7 1.6 1.9 1.4
Leukemia 6.4 7.2 5.5 5.3 6.2 4.5
Other and ill defined 32.0 32.6 31.4 19.7 22.6 17.4

CNS, central nervous system.

a) Age-adjusted using the Segi’s world standard population,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 3.
The top 10 leading causes of death in Korea, 2015
Rank Cause of death No. of deaths (%) Age-standardized death rate per 100,000a)
All causes 275,895 (100) 289.3
1 Cancer 76,855 (27.9) 82.0
2 Heart disease 28,326 (10.3) 27.9
3 Cerebrovascular disease 24,455 (8.9) 23.4
4 Pneumonia 14,718 (5.3) 13.5
5 Intentional self-harm (suicide) 13,513 (4.9) 18.3
6 Diabetes mellitus 10,558 (3.8) 10.2
7 Chronic lower respiratory diseases 7,538 (2.7) 6.8
8 Disease of liver 6,847 (2.5) 8.1
9 Transport accidents 5,539 (2.0) 7.6
10 Hypertensive diseases 5,050 (1.8) 4.6
Others 82,496 (29.9) 87.1

Source: Mortality Data, 2015, Statistics Korea [8].

a) Age-adjusted using the Segi’s world standard population.

Table 4.
Crude and age-standardized cancer mortality rates by sex in Korea, 2015
Site/Type Crude mortality rate per 100,000
Age-standardized mortality rate per 100,000a)
Both sexes Men Women Both sexes Men Women
All sites 150.8 187.3 114.4 82.0 119.6 54.6
Lip, oral cavity, and pharynx 2.3 3.5 1.1 1.3 2.3 0.6
Esophagus 3.0 5.5 0.5 1.6 3.4 0.2
Stomach 16.7 21.6 11.8 8.9 13.8 5.4
Colon and rectum 16.3 18.5 14.1 8.5 11.8 6.1
Liver 22.2 32.9 11.5 12.6 20.9 5.4
Gallbladderb) 8.3 8.4 8.1 4.2 5.3 3.4
Pancreas 10.7 11.4 9.9 5.7 7.2 4.5
Larynx 0.7 1.3 0.1 0.4 0.8 0.0
Lung 34.1 49.8 18.5 17.9 31.2 8.2
Breast 4.6 0.1 9.2 2.8 0.0 5.5
Cervix uteri 1.9 - 3.8 1.1 - 2.0
Corpus uteri 0.6 - 1.3 0.4 - 0.7
Ovary 2.1 - 4.1 1.2 - 2.2
Prostate 3.3 6.7 - 1.6 4.3 -
Testis 0.0 0.0 - 0.0 0.0 -
Kidney 1.9 2.6 1.1 1.0 1.7 0.5
Bladder 2.5 3.8 1.3 1.2 2.4 0.5
Brain and CNS 2.5 2.6 2.3 1.7 1.9 1.5
Thyroid 0.7 0.4 0.9 0.3 0.3 0.4
Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
Non-Hodgkin lymphoma 3.5 4.0 2.9 2.0 2.7 1.4
Multiple myeloma 1.7 1.8 1.7 1.0 1.2 0.8
Leukemia 3.4 3.9 2.8 2.2 2.8 1.7
Other and ill defined 7.7 8.3 7.2 4.3 5.5 3.5

CNS, central nervous system.

a) Age-adjusted using the world standard population,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 5.
Trends in cancer incidence rates from 1999 to 2015 in Korea
Site/Type Both sexes
Men
Women
1999 2015 Trend 1
Trend 2
1999 2015 Trend 1
Trend 2
1999 2015 Trend 1
Trend 2
Year APC Year APC Year APC Year APC Year APC Year APC
All sites 210.5 258.9 1999-2012 3.4a) 2012-2015 –6.1a) 285.0 291.7 1999-2011 1.7a) 2011-2015 –3.6a) 161.1 241.1 1999-2012 5.5a) 2012-2015 –7.5a)
Lip, oral cavity, and pharynx 3.6 4.1 1999-2015 0.5a) - - 6.1 6.2 1999-2015 –0.2 - - 1.6 2.2 1999-2015 1.4a) - -
Esophagus 4.1 2.7 1999-2015 –2.3a) - - 8.8 5.5 1999-2015 –2.7a) - - 0.6 0.4 1999-2015 –1.8a) - -
Stomach 43.6 33.8 1999-2011 –0.1 2011-2015 –5.7a) 66.2 49.3 1999-2011 –0.3 2011-2015 –6.2a) 26.7 20.5 1999-2011 –0.3 2011-2015 –5.1a)
Colon and rectum 20.4 30.4 1999-2010 6.0a) 2010-2015 –4.9a) 26.2 40.2 1999-2010 6.5a) 2010-2015 –5.4a) 16.4 22.2 1999-2010 4.9a) 2010-2015 –4.3a)
Liver 27.9 18.2 1999-2010 –1.7a) 2010-2015 –4.6a) 46.8 29.5 1999-2009 –1.9a) 2009-2015 –4.2a) 12.3 8.2 1999-2010 –1.5a) 2010-2015 –5.0a)
Gallbladderb) 6.5 6.6 1999-2004 1.5 2004-2015 –0.3 8.1 8.0 1999-2015 0.0 - - 5.4 5.5 1999-2003 2.5 2003-2015 –0.6a)
Pancreas 5.6 7.0 1999-2015 1.4a) - - 7.8 8.5 1999-2015 0.7a) - - 4.0 5.7 1999-2015 2.2a) - -
Larynx 2.3 1.3 1999-2015 –3.6a) - - 4.9 2.7 1999-2015 –3.8a) - - 0.4 0.1 1999-2007 –8.9a) 2007-2015 –4.2a)
Lung 28.5 26.4 1999-2011 0.1 2011-2015 –1.8a) 51.4 42.3 1999-2005 –0.1 2005-2015 –1.6a) 12.4 14.3 1999-2012 1.9a) 2012-2015 –2.0
Breast 10.7 24.8 1999-2007 6.9a) 2007-2015 4.0a) 0.2 0.2 1999-2015 –1.1 - - 20.9 49.2 1999-2007 7.1a) 2007-2015 4.1a)
Cervix uteri 8.5 4.6 1999-2015 –3.9a) - - - - - - - - 16.3 9.1 1999-2015 –3.7a) - -
Corpus uteri 1.4 3.1 1999-2009 6.2a) 2009-2015 3.1a) - - - - - - 2.8 6.1 1999-2009 6.4a) 2009-2015 3.3a)
Ovary 2.7 3.2 1999-2015 1.6a) - - - - - - - - 5.0 6.3 1999-2015 1.8a) - -
Prostate 3.1 11.2 1999-2009 15.3a) 2009-2015 0.3 8.4 25.4 1999-2009 13.7a) 2009-2015 –0.5 - - - - - -
Testis 0.3 0.6 1999-2015 4.9a) - - 0.6 1.1 1999-2015 4.8a) - - - - - - - -
Kidney 3.0 5.7 1999-2009 6.7a) 2009-2015 1.3a) 4.5 8.2 1999-2010 6.1a) 2010-2015 0.4 1.7 3.4 1999-2009 6.6a) 2009-2015 1.1
Bladder 4.6 4.3 1999-2004 2.4a) 2004-2015 –1.5a) 9.0 8.1 1999-2005 1.5a) 2005-2015 –1.8a) 1.6 1.5 1999-2003 2.6 2003-2015 –1.7a)
Brain and CNS 2.9 2.8 1999-2008 1.3a) 2008-2015 –1.6a) 3.2 3.1 1999-2009 1.2a) 2009-2015 –2.0 2.6 2.4 1999-2007 1.5 2007-2015 –1.5a)
Thyroid 6.3 35.2 1999-2011 22.8a) 2011-2015 –13.3a) 2.1 15.1 1999-2012 22.9a) 2012-2015 –16.9a) 10.4 55.6 1999-2011 22.4a) 2011-2015 –14.4a)
Hodgkin lymphoma 0.2 0.5 1999-2015 4.1a) - - 0.4 0.6 1999-2015 3.2a) - - 0.1 0.4 1999-2015 5.3a) - -
Non-Hodgkin lymphoma 4.3 5.9 1999-2015 2.3a) - - 5.6 7.2 1999-2015 1.9a) - - 3.3 4.6 1999-2015 2.6a) - -
Multiple myeloma 1.0 1.6 1999-2015 3.3a) - - 1.2 1.9 1999-2015 3.0a) - - 0.8 1.4 1999-2015 3.5a) - -
Leukemia 4.7 5.3 1999-2015 0.9a) - - 5.5 6.2 1999-2015 1.0a) - - 3.9 4.5 1999-2015 0.7a) - -
Other and ill defined 14.4 19.7 1999-2008 3.5a) 2008-2015 1.3a) 18.1 22.6 1999-2015 1.8a) - - 11.9 17.4 1999-2011 3.8a) 2011-2015 –0.3

APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 6.
Trends in cancer mortality rates from 1999 to 2015 in Korea
Site/Type Both sexes
Men
Women
1999 2015 Trend 1
Trend 2
1999 2015 Trend 1
Trend 2
1999 2015 Trend 1
Trend 2
Year APC Year APC Year APC Year APC Year APC Year APC
All sites 114.3 82.0 1999-2002 1.0 2002-2015 –2.7a) 176.6 119.6 1999-2002 1.2 2002-2015 –3.1a) 70.6 54.6 1999-2002 1.0 2002-2015 –2.2a)
Lip, oral cavity, and pharynx 1.1 1.3 1999-2015 –1.8a) - - 2.0 2.3 1999-2015 –2.1a) - - 0.4 0.6 1999-2015 –2.7a) - -
Esophagus 3.1 1.6 1999-2015 –4.4a) - - 6.8 3.4 1999-2015 –4.6a) - - 0.5 0.2 1999-2015 –5.1a) - -
Stomach 23.8 8.9 1999-2003 –3.3a) 2003-2015 –6.7a) 36.9 13.8 1999-2003 –2.6a) 2003-2015 –7.0a) 14.6 5.4 1999-2003 –4.4a) 2003-2015 –6.6a)
Colon and rectum 7.7 8.5 1999-2004 5.5a) 2004-2015 –1.3a) 10.5 11.8 1999-2004 5.9a) 2004-2015 –1.0a) 6.0 6.1 1999-2004 4.9a) 2004-2015 –1.8a)
Liver 20.4 12.6 1999-2002 0.8 2002-2015 –3.6a) 35.3 20.9 1999-2002 –0.1 2002-2015 –3.7a) 8.3 5.4 1999-2002 2.9 2002-2015 –3.7a)
Gallbladderb) 5.2 4.2 1999-2001 7.4 2001-2015 –2.7a) 6.8 5.3 1999-2001 6.2 2001-2015 –2.8a) 4.1 3.4 1999-2001 9.2 2001-2015 –2.6a)
Pancreas 5.4 5.7 1999-2015 0.3a) - - 7.6 7.2 1999-2015 –0.4a) - - 3.9 4.5 1999-2015 0.9a) - -
Larynx 1.6 0.4 1999-2015 –9.5a) - - 3.4 0.8 1999-2015 –9.1a) - - 0.4 0.0 1999-2010 –15.4a) 2010-2015 –6.2
Lung 22.4 17.9 1999-2002 1.8 2002-2015 –2.1a) 41.5 31.2 1999-2001 4.3 2001-2015 –2.5a) 9.4 8.2 1999-2002 2.3 2002-2015 –1.5a)
Breast 2.2 2.8 1999-2015 1.4a) - - 0.1 0.0 1999-2015 –4.5a) - - 4.2 5.5 1999-2015 1.7a) - -
Cervix uteri 1.4 1.1 1999-2003 8.4a) 2003-2015 –5.2a) - - - - - - 2.6 2.0 1999-2003 7.8a) 2003-2015 –4.9a)
Corpus uteri 0.1 0.4 1999-2002 51.8a) 2002-2015 3.4a) - - - - - - 0.1 0.7 1999-2002 51.6a) 2002-2015 3.8a)
Ovary 0.9 1.2 1999-2001 10.9 2001-2015 0.2 - - - - - - 1.7 2.2 1999-2001 10.2 2001-2015 0.5
Prostate 0.9 1.6 1999-2004 9.4a) 2004-2015 0.4 2.6 4.3 1999-2002 17.5a) 2002-2015 0.3 - - - - - -
Testis 0.0 0.0 1999-2015 –2.5 - - 0.1 0.0 1999-2015 2.9 - - - - - - - -
Kidney 1.1 1.0 1999-2015 –0.1 - - 1.8 1.7 1999-2015 0.0 - - 0.5 0.5 1999-2015 –0.8 - -
Bladder 1.3 1.2 1999-2015 –1.3a) - - 2.6 2.4 1999-2015 –1.6a) - - 0.5 0.5 1999-2001 10.8 2001-2015 –1.9a)
Brain and CNS 1.9 1.7 1999-2002 4.4 2002-2015 –2.0a) 2.2 1.9 1999-2015 –1.5a) - - 1.6 1.5 1999-2015 –1.4a) - -
Thyroid 0.4 0.3 1999-2003 7.0 2003-2015 –4.2a) 0.3 0.3 1999-2002 16.0 2002-2015 –4.0a) 0.5 0.4 1999-2004 4.3 2004-2015 –4.7a)
Hodgkin lymphoma 0.0 0.1 1999-2003 29.6 2003-2015 –0.2 0.0 0.1 1999-2004 19.2a) 2004-2015 –2.0 0.0 0.0 1999-2003 40.8 2003-2015 1.3
Non-Hodgkin lymphoma 2.1 2.0 1999-2015 –0.5a) - - 3.0 2.7 1999-2015 –0.8a) - - 1.4 1.4 1999-2015 –0.2 - -
Multiple myeloma 0.6 1.0 1999-2003 12.8a) 2003-2015 0.8 0.8 1.2 1999-2003 10.9a) 2003-2015 0.8 0.4 0.8 1999-2007 7.4a) 2007-2015 –1.1
Leukemia 2.9 2.2 1999-2001 1.4 2001-2015 –2.1a) 3.5 2.8 1999-2015 –1.7a) - - 2.4 1.7 1999-2015 –2.1a) - -
Other and ill defined 7.8 4.3 1999-2015 –3.1a) - - 9.0 5.5 1999-2009 –0.6 2009-2015 –6.8a) 7.0 3.5 1999-2005 –7.0a) 2005-2015 –2.2a)

APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 7.
The five common sites/types of cancer incidence by age group and sex in Korea, 2015
Rank Age (yr)
0-14 15-34 35-64 ≥ 65
Men
 1 Leukemia (4.7) Thyroid (11.9) Stomach (81.9) Lung (436.0)
 2 Non-Hodgkin lymphoma (2.7) Leukemia (3.8) Colon and rectum (62.9) Stomach (353.5)
 3 Brain and CNS (1.9) Non-Hodgkin lymphoma (2.8) Liver (56.9) Colon and rectum (300.4)
 4 Kidney (0.5) Colon and rectum (2.7) Lung (42.1) Prostate (284.2)
 5 Liver (0.4) Testis (2.3) Thyroid (33.7) Liver (178.7)
Women
 1 Leukemia (4.1) Thyroid (45.9) Breast (132.5) Colon and rectum (168.4)
 2 Brain and CNS (1.6) Breast (10.9) Thyroid (125.6) Stomach (137.0)
 3 Non-Hodgkin lymphoma (1.5) Cervix uteri (5.2) Colon and rectum (37.0) Lung (122.1)
 4 Thyroid (0.9) Ovary (3.0) Stomach (36.5) Breast (78.2)
 5 Ovary (0.6) Stomach (2.9) Lung (21.9) Live (66.3)

CNS, central nervous system.

Table 8.
Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2015 in Korea
Site/Type Both sexes
Men
Women
1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 Changea)
All sites 41.2 44.0 54.0 65.2 70.7 29.5 31.7 35.3 45.4 56.5 62.8 31.1 53.4 55.3 64.2 74.2 78.4 25.0
Lip, oral cavity, and pharynx 41.1 46.7 54.3 60.6 64.5 23.4 35.8 41.1 49.4 56.4 60.7 24.9 58.1 63.8 67.8 71.7 74.1 16.0
Esophagus 12.7 15.2 21.4 29.6 36.0 23.3 11.8 14.3 20.6 29.0 35.7 23.9 23.7 24.2 29.7 36.5 39.3 15.6
Stomach 42.8 46.6 57.8 68.1 75.4 32.6 43.0 46.9 58.4 68.7 76.3 33.3 42.6 46.0 56.5 66.7 73.7 31.1
Colon and rectum 54.8 58.0 66.7 73.5 76.3 21.5 55.3 59.0 68.5 75.4 78.0 22.7 54.2 56.8 64.3 70.8 73.6 19.4
Liver 10.7 13.2 20.4 28.1 33.6 22.9 9.9 12.9 20.3 28.1 34.1 24.2 13.6 14.2 20.9 28.1 32.2 18.6
Gallbladderb) 17.3 19.7 23.1 26.8 29.1 11.8 16.6 20.3 23.5 27.7 30.2 13.6 18.0 19.1 22.7 25.9 28.0 10.0
Pancreas 9.4 7.6 8.4 8.4 10.8 1.4 8.8 7.3 8.4 8.1 10.3 1.5 10.1 8.1 8.5 8.7 11.5 1.4
Larynx 59.7 62.3 66.3 72.9 75.5 15.8 60.2 62.8 66.9 73.2 75.9 15.7 55.4 57.8 58.9 67.6 69.9 14.5
Lung 11.3 12.7 16.5 20.1 26.7 15.4 10.4 11.6 15.2 17.9 22.7 12.3 14.2 16.2 20.1 25.8 35.8 21.6
Breast 77.9 83.2 88.6 91.1 92.3 14.4 75.1 85.6 87.2 89.9 87.1 12.0 78.0 83.2 88.6 91.1 92.3 14.3
Cervix uteri 77.5 80.0 81.4 80.5 79.9 2.4 - - - - - - 77.5 80.0 81.4 80.5 79.9 2.4
Corpus uteri 81.5 81.8 84.5 86.4 87.8 6.3 - - - - - - 81.5 81.8 84.5 86.4 87.8 6.3
Ovary 58.7 58.9 61.8 61.1 64.1 5.4 - - - - - - 58.7 58.9 61.8 61.1 64.1 5.4
Prostate 55.9 67.2 80.4 91.1 94.1 38.2 55.9 67.2 80.4 91.1 94.1 38.2 - - - - - -
Testis 85.4 90.4 90.7 93.1 95.6 10.2 85.4 90.4 90.7 93.1 95.6 10.2 - - - - - -
Kidney 62.0 66.1 73.6 78.4 82.2 20.2 60.8 64.4 73.0 78.2 81.6 20.8 64.5 69.7 74.7 78.8 83.6 19.1
Bladder 69.1 73.1 75.7 76.7 75.8 6.7 70.0 74.8 77.5 78.8 77.8 7.8 65.5 66.3 68.8 68.6 67.7 2.2
Brain and CNS 38.5 39.0 40.9 42.8 40.7 2.2 37.2 37.5 40.2 41.4 39.1 1.9 40.2 40.7 41.7 44.4 42.6 2.4
Thyroid 94.2 94.9 98.4 99.9 100.3 6.1 87.2 89.5 96.0 100.1 100.6 13.4 95.4 95.9 98.7 99.9 100.2 4.8
Hodgkin lymphoma 68.0 71.2 76.7 81.0 82.2 14.2 67.6 68.1 74.7 80.7 82.8 15.2 68.6 77.4 80.7 81.6 81.2 12.6
Non-Hodgkin lymphoma 46.6 50.8 55.9 59.3 62.9 16.3 45.3 48.9 54.9 59.1 62.4 17.1 48.7 53.5 57.4 59.6 63.6 14.9
Multiple myeloma 22.1 19.8 29.6 34.9 40.9 18.8 21.1 17.8 29.8 35.0 40.6 19.5 23.3 22.1 29.4 34.8 41.3 18.0
Leukemia 26.5 33.3 42.0 47.6 51.0 24.5 26.2 32.3 41.8 46.8 51.1 24.9 26.8 34.6 42.2 48.6 50.8 24.0
Other and ill defined 42.1 45.9 57.6 67.2 72.2 30.1 37.4 42.4 53.8 63.4 68.9 31.5 47.4 50.0 61.8 71.0 75.5 28.1

CNS, central nervous system.

a) Percentage change in 5-year relative survival from 1993 to 1995 and 2011 to 2015,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 9.
Crude and age-standardized rates of cancer prevalence by sex on January 1, 2016 in Korea
Site/Type Crude prevalence rate per 100,000a)
Age-standardized prevalence rate per 100,000b)
Both sexes Men Women Both sexes Men Women
All sites 3,162.8 2,781.0 3,544.1 1,956.9 1,826.6 2,171.5
Lip, oral cavity, and pharynx 42.8 57.6 28.1 26.8 37.9 17.2
Esophagus 18.0 32.5 3.6 10.3 20.6 1.8
Stomach 504.4 668.9 340.1 291.5 425.6 180.9
Colon and rectum 433.1 516.8 349.4 248.2 330.6 181.7
Liver 120.3 180.2 60.4 73.5 116.8 34.2
Gallbladderc) 38.2 39.1 37.3 21.1 24.7 18.4
Pancreas 18.7 19.8 17.6 11.1 12.9 9.7
Larynx 19.7 37.1 2.3 11.2 23.6 1.2
Lung 137.2 172.8 101.8 78.7 110.2 54.5
Breast 351.5 2.7 699.8 221.7 1.7 435.9
Cervix uteri 99.1 - 198.0 61.5 - 120.0
Corpus uteri 40.9 - 81.8 26.1 - 51.2
Ovary 35.5 - 71.0 24.2 - 48.1
Prostate 136.3 272.8 - 71.3 170.0 -
Testis 5.8 11.5 - 5.2 10.3 -
Kidney 69.3 93.7 45.0 43.5 62.0 27.1
Bladder 61.6 100.6 22.7 33.7 64.1 10.6
Brain and CNS 20.3 21.0 19.7 17.2 18.3 16.1
Thyroid 696.8 236.3 1,156.8 464.9 160.2 767.5
Hodgkin lymphoma 5.0 6.4 3.7 4.2 5.1 3.2
Non-Hodgkin lymphoma 53.9 61.4 46.5 38.2 45.9 31.1
Multiple myeloma 10.5 10.9 10.0 6.1 7.0 5.4
Leukemia 37.8 41.8 33.8 35.2 39.2 31.1
Other and ill defined 205.9 197.1 214.6 131.4 139.9 124.4

CNS, central nervous system.

a) Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2015 and who were alive on January 1, 2016. Multiple primary cancer cases were counted multiple times,

b) Age-adjusted using the Segi’s world standard population,

c) Includes the gallbladder and other/unspecified parts of the biliary tract.

  • 1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer; 2013. [cited 2017 Jan 20]. Available from: http://globocan.iarc.fr
  • 2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71. ArticlePubMed
  • 3. Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 2017;49:292–305. ArticlePubMedPMCPDF
  • 4. Jung KW, Won YJ, Oh CM, Kong HJ, Cho H, Lee DH, et al. Prediction of cancer incidence and mortality in Korea, 2015. Cancer Res Treat. 2015;47:142–8. ArticlePubMedPMCPDF
  • 5. Lee KS, Chang HS, Lee SM, Park EC. Economic burden of cancer in Korea during 2000-2010. Cancer Res Treat. 2015;47:387–98. ArticlePubMedPMCPDF
  • 6. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999-2001: first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–31. ArticlePubMedPMCPDF
  • 7. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. Nihon Koshu Eisei Zasshi. 1998;45:1011–7. PubMed
  • 8. Statistics Korea [Internet]. Daejeon: Statistics Korea; 2017. [cited 2017 Jan 28]. Available from: http://kosis.kr
  • 9. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
  • 10. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. ed. Geneva: World Health Organization; 1994.
  • 11. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2013 [Internet]. Bethesda, MD: National Cancer Institute; 2016. [cited 2017 Feb 20]. Available from: http://seer.cancer.gov/csr/1975_2013/
  • 12. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine; 1960.
  • 13. Day NE. Cumulative rates and cumulative risk. In: Muir C, Waterhouse J, Mack T, Powell J, Whelan S, editors. Cancer incidence in five continents, Vol. V. IARC Scientific Publications No. 88. Lyon: International Agency for Research on Cancer; 1987. p. 787–9.
  • 14. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note No. 10. Bethesda, MD: National Cancer Institute; 1959.
  • 15. Paul Dickman [Internet]. Stockholm: PaulDickman.com; 2016. [cited 2016 Jan 14]. Available from: http//www.pauldickman.com

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Sensitivity, Specificity, and Cost–Benefit Effect Between Primary Human Papillomavirus Testing, Primary Liquid‐Based Cytology, and Co‐Testing Algorithms for Cervical Lesions
      Chang Gok Woo, Seung‐Myoung Son, Hye‐Kyung Hwang, Jung‐Sil Bae, Ok‐Jun Lee, Ho‐Chang Lee
      Diagnostic Cytopathology.2025; 53(1): 35.     CrossRef
    • Multistage deep learning for classification of Helicobacter pylori infection status using endoscopic images
      Guang Li, Ren Togo, Katsuhiro Mabe, Shunpei Nishida, Yoshihiro Tomoda, Fumiyuki Shiratani, Masashi Hirota, Takahiro Ogawa, Miki Haseyama
      Journal of Gastroenterology.2025;[Epub]     CrossRef
    • Recent 5‑year trends in biliary tract cancer survival rates: An analytical big data survey
      Ji Yoon Lee, Ju Won Kim
      Medicine International.2025;[Epub]     CrossRef
    • Research Progress in ESD Treatment of Early Gastric Cancer
      亭 贺
      Advances in Clinical Medicine.2024; 14(02): 4201.     CrossRef
    • Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study
      Yoon Young Choi, Myeongjee Lee, Eun Hwa Kim, Jae Eun Lee, Inkyung Jung, Jae-Ho Cheong
      JMIR Public Health and Surveillance.2024; 10: e48380.     CrossRef
    • Nature and Determinants of Fear of Cancer Recurrence After Endoscopic Submucosal Dissection for Early Gastric Cancer
      Nian Song, Xiaotao Zhang, Jie Su, Lu Chen, Qianhong Jin, Chengcheng Liu, Zhengxiang Dai
      Gastroenterology Nursing.2024; 47(5): 358.     CrossRef
    • The effect of circulating tumor DNA on the prognosis of patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis
      Ruoyi Yang, Teng Li, Sicheng Zhang, Chunyan Shui, Hong Ma, Chao Li
      BMC Cancer.2024;[Epub]     CrossRef
    • Contrasting income-based inequalities in incidence and mortality of breast cancer in Korea, 2006-2015
      Jinwook Bahk, Hee-Yeon Kang, Young-Ho Khang, Kyunghee Jung-Choi
      Epidemiology and Health.2024; 46: e2024074.     CrossRef
    • Anticancer activity of herbal formula Jisilhaebaekgyeji-Tang against human breast cancer cells and its mechanism
      Sang Kyu Jeon, Su Mi Park, Jung Yun Ahn, Ok Hyeon Kim, Young Woo Kim, Kwang-Il Park, Sun-Dong Park, Ju-Hee Lee
      Molecular & Cellular Toxicology.2023; 19(3): 437.     CrossRef
    • Endoscopy-assisted latissimus dorsi muscle flap harvesting technique for immediate breast reconstruction
      Y. Cha, S. Lee
      Annales de Chirurgie Plastique Esthétique.2023; 68(4): 308.     CrossRef
    • RGO-PANI composite Au microelectrodes for sensitive ECIS analysis of human gastric (MKN-1) cancer cells
      Ajay Kumar Yagati, Sachin Ganpat Chavan, Changyoon Baek, Donghyun Lee, Min-Ho Lee, Junhong Min
      Bioelectrochemistry.2023; 150: 108347.     CrossRef
    • Updated epidemiology of gastrointestinal cancers in East Asia
      Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong
      Nature Reviews Gastroenterology & Hepatology.2023; 20(5): 271.     CrossRef
    • Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea
      Si Won Lee, Jung Hye Kwon, Seung-hoon Beom, Sang Joon Shin, Hyo Song Kim, Sun Young Rha, Minkyu Jung, Joo Hyuk Sohn, Joong-Bae Ahn, Hyun Cheol Chung, Gun Min Kim, Hye Ryun Kim, Beodeul Kang, Youn Jung Hu, Hye Jin Choi
      Palliative Medicine Reports.2023; 4(1): 9.     CrossRef
    • Gold nanoparticles combined baker’s yeast as a successful approach for breast cancer treatment
      Amany Elwakkad, Amina A. Gamal el Din, Hisham A. Saleh, Noha E. Ibrahim, Mohamed A. Hebishy, Hagar H. Mourad, Mahitab I. El-Kassaby, Howida Sayed Abou-Seif, Ghada M. Elqattan
      Journal of Genetic Engineering and Biotechnology.2023; 21(1): 27.     CrossRef
    • Updates on global epidemiology, risk and prognostic factors of gastric cancer
      Wen-Juan Yang, He-Ping Zhao, Yan Yu, Ji-Han Wang, Lei Guo, Jun-Ye Liu, Jie Pu, Jing Lv
      World Journal of Gastroenterology.2023; 29(16): 2452.     CrossRef
    • Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study
      Soheil Hassanipour, Reza Zare, Alireza Shahedi, Hamed Delam
      Endocrine.2023; 82(2): 237.     CrossRef
    • Chasm between Public Perceptions and Epidemiological Data on Colorectal Cancer
      Su Bee Park, Min Seob Kwak, Jin Young Yoon, Jae Myung Cha
      Gut and Liver.2023; 17(3): 449.     CrossRef
    • Harmful effect of repetitive intravenous iodinated contrast media administration on the long-term renal function of patients with early gastric cancer
      Ja Ho Koo, Myeongjee Lee, Eun Hwa Kim, Hyung Jung Oh, Joon Seok Lim, Woo Jin Hyung, Hong In Yoon, Inkyung Jung, Yong Eun Chung
      Scientific Reports.2023;[Epub]     CrossRef
    • Clinical and Biological Profile of Metastatic Colorectal Cancers Treated at the Bejaia University Hospital Center. About a Series of 93 Patients
      Chahira Mazouzi, Rachida Aftis, Radia Benyahia, Kamel Hail, Nabil Blik
      European Journal of Medical and Health Research.2023; 1(1): 34.     CrossRef
    • Applications of competing risks analysis in public health
      Hyunsoon Cho, Dahhay Lee, Sanghee Lee, Sangbum Choi
      Journal of the Korean Statistical Society.2022; 51(1): 1.     CrossRef
    • Coffee Intake Interacted with the Bcl-2 rs1944420, rs7236090, and rs2849382 Haplotype to Influence Breast Cancer Risk in Middle-Aged Women
      Meiling Liu, Sang Shin Song, Sunmin Park
      Nutrition and Cancer.2022; 74(1): 131.     CrossRef
    • Effects of melatonin receptor expression on prognosis and survival in oral squamous cell carcinoma patients
      H.-K. Park, M.-H. Ryu, D.-S. Hwang, G.-C. Kim, M.-A. Jang, U.-K. Kim
      International Journal of Oral and Maxillofacial Surgery.2022; 51(6): 713.     CrossRef
    • Deep learning model for diagnosing gastric mucosal lesions using endoscopic images: development, validation, and method comparison
      Joon Yeul Nam, Hyung Jin Chung, Kyu Sung Choi, Hyuk Lee, Tae Jun Kim, Hosim Soh, Eun Ae Kang, Soo-Jeong Cho, Jong Chul Ye, Jong Pil Im, Sang Gyun Kim, Joo Sung Kim, Hyunsoo Chung, Jeong-Hoon Lee
      Gastrointestinal Endoscopy.2022; 95(2): 258.     CrossRef
    • Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South Korea
      Diego Novick, Jae Min Cho, Sam Colman, Agota Szende
      Drugs - Real World Outcomes.2022; 9(2): 263.     CrossRef
    • The diagnostic value of digital breast tomosynthesis with complementary ultrasound in comparison with magnetic resonance imaging in assessment of postoperative changes and locoregional recurrence of breast cancer
      Mai M. K. Barakat, Eman K. A. E. Mohamed, Lobna A. E. Habib, Mortada Elsayed Ahmed
      Egyptian Journal of Radiology and Nuclear Medicine.2022;[Epub]     CrossRef
    • Morning Chronotype Decreases the Risk of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer
      Kyung-Lak Son, Dooyoung Jung, Kwang-Min Lee, Chan-Woo Yeom, Gyu Han Oh, Tae-Yong Kim, Seock-Ah Im, Kyung-Hun Lee, David Spiegel, Bong-Jin Hahm
      Journal of Korean Medical Science.2022;[Epub]     CrossRef
    • Long non-coding RNA Opa interacting protein 5-antisense RNA 1 binds to micorRNA-34a to upregulate oncogenic PD-L1 in non-small cell lung cancer
      Xinwei Qiao, Feng Zhao
      Bioengineered.2022; 13(4): 9264.     CrossRef
    • Quality of life changes in elderly patients after gastrectomy: perspective of an aged Asian society in the 2010s
      Ji Hyun Jung, Seung Soo Lee, Ho Young Chung
      Annals of Surgical Treatment and Research.2022; 102(4): 214.     CrossRef
    • Deep-Learning-Based Automatic Detection and Segmentation of Brain Metastases with Small Volume for Stereotactic Ablative Radiotherapy
      Sang Kyun Yoo, Tae Hyung Kim, Jaehee Chun, Byong Su Choi, Hojin Kim, Sejung Yang, Hong In Yoon, Jin Sung Kim
      Cancers.2022; 14(10): 2555.     CrossRef
    • PD-L1 Expression and Overall Survival in Asian and Western Patients with Gastric Cancer
      Sun Young Rha, Geoffrey Y Ku, Hyo Song Kim, Hyun Cheol Chung, Fatemeh Ghazanfari Amlashi, Dipen Maheshbhai Maru, Carly A Fein, Laura H Tang, Wei Zhou, Ting Wu, Senaka A Peter, David P Kelsen, Jaffer A Ajani
      Future Oncology.2022; 18(21): 2623.     CrossRef
    • Lung Cancer Patients’ Characteristics and Comorbidities Using the Korean National Hospital Discharge In-depth Injury Survey Data
      Kyunghee Lee, Sunghong Kang, Jieun Hwang
      Journal of Epidemiology and Global Health.2022; 12(3): 258.     CrossRef
    • Estimation of Utility Weights for Prostate-related Health States in Korea
      Seon-Ha Kim, Minsu Ock, Min-Woo Jo, Sungchan Park
      Journal of Preventive Medicine and Public Health.2022; 55(3): 243.     CrossRef
    • Induction of the BRAFV600E Mutation in Thyroid Cells Leads to Frequent Hypermethylation
      Jin Wook Yi, Seong Yun Ha, Hyeon-Gun Jee, Kwangsoo Kim, Su-jin Kim, Young Jun Chai, June Young Choi, Kyu Eun Lee
      Clinical and Experimental Otorhinolaryngology.2022; 15(3): 273.     CrossRef
    • Oncological impact of vascular invasion in colon cancer might differ depending on tumor sidedness
      Moamen Shalkamy Abdelgawaad Shalkamy, Jung Hoon Bae, Chul Seung Lee, Seung Rim Han, Ji Hoon Kim, Bong-Hyeon Kye, In Kyu Lee, Yoon Suk Lee
      Journal of Minimally Invasive Surgery.2022; 25(2): 53.     CrossRef
    • Relationship between Health Behaviors and Metabolic Syndrome in Cancer Survivors in Korea: Korean National Health and Nutrition Examination Survey, 2013–2018
      Nayoung Kim, Seohwan Kim, Bong Gyu Choi, Yong Uk Ko, Kyoung ah Park
      Korean Journal of Family Practice.2022; 12(3): 144.     CrossRef
    • Clinicopathologic characteristics and survival of patients with double primary malignancies: breast and colorectal cancer
      Hyundo Lee, Hae Won Lee, Eun Jung Park, Jeonghyun Kang, Seung Hyuk Baik
      Annals of Coloproctology.2022; 38(3): 197.     CrossRef
    • Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019
      Juhee Park, Kyeongjun Moon, Dong-Sook Kim
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in Korea
      Diego Novick, Sae Young Lee, Dong Hyun Koo, Agota Szende, Sam Colman
      Journal of Drug Assessment.2022; 11(1): 12.     CrossRef
    • MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression
      Shihyun Kim, Suyeon Park, Ji-Hyeon Oh, Sang Shin Lee, Yoon Lee, Jongho Choi
      BMC Oral Health.2022;[Epub]     CrossRef
    • Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy
      Song Yi Park, Koung Jin Suh, Dae-Won Lee, Han Suk Ryu, Miso Kim, Se Hyun Kim, Kyung-Hun Lee, Tae-Yong Kim, Jee Hyun Kim, In Ae Park, Seock-Ah Im
      Breast Cancer Research and Treatment.2022; 196(1): 121.     CrossRef
    • The Role of Serum CD26 in the Diagnosis of Gastric Cancer
      Ju Yup Lee, Mae-Ja Park
      International Journal of General Medicine.2022; Volume 15: 7179.     CrossRef
    • Radiomics Nomogram: Prediction of 2-Year Disease-Free Survival in Young Age Breast Cancer
      Jeongmin Lee, Sung Hun Kim, Yelin Kim, Jaewoo Park, Ga Eun Park, Bong Joo Kang
      Cancers.2022; 14(18): 4461.     CrossRef
    • Whole-Transcriptome Sequencing Reveals Characteristics of Cancer Microbiome in Korean Patients with GI Tract Cancer: Fusobacterium nucleatum as a Therapeutic Target
      Hyeok Ahn, Kyungchan Min, Eulgi Lee, Hyun Kim, Sujeong Kim, Yunjae Kim, Gihyeon Kim, Beomki Cho, Chanyeong Jeong, Yeongmin Kim, Hansoo Park
      Microorganisms.2022; 10(10): 1896.     CrossRef
    • Validity and reproducibility of a food frequency questionnaire for breast cancer survivors in Korea
      Sang-Eun Moon, Woo-kyoung Shin, Sihan Song, Dahye Koh, Jeong Sun Ahn, Youngbum Yoo, Minji Kang, Jung Eun Lee
      Nutrition Research and Practice.2022; 16(6): 789.     CrossRef
    • Status of dyslipidemia management and statin undertreatment in Korean cancer survivors: A Korean National Health and Nutrition Examination Survey study
      Sujeong Shin, Dong Wook Shin, In Young Cho, Su-Min Jeong, Hyein Jung
      European Journal of Preventive Cardiology.2021; 28(8): 864.     CrossRef
    • Development of all-in-one phantom dosimeter to measure multidimensional dose distribution for 60Co radiotherapy unit
      Hyun Young Shin, Jin Ho Kim, Si Won Song, Jinhong Kim, Bongsoo Lee, Joohyun Moon, Cheol Ho Pyeon
      Journal of the Korean Physical Society.2021; 78(9): 829.     CrossRef
    • Korean college students’ attitudes and health behaviour regarding human papillomavirus vaccination
      Sun Young Kim, Ju Won Seo, Eunjung Ryu
      Collegian.2021; 28(1): 57.     CrossRef
    • Clinical and imaging findings suggestive of histopathological immunoglobulin G4-related disease: a single-center retrospective study
      Byung-Woo Yoo, Sang-Won Lee, Jason Jungsik Song, Yong-Beom Park, Seung Min Jung
      Clinical Rheumatology.2021; 40(4): 1423.     CrossRef
    • Monocyte subsets to differentiate chronic myelomonocytic leukemia from reactive monocytosis
      Sang Mee Hwang, Haejin Ahn, Seungah Jeon, Jun Park, Yunye Chang, Hyungsuk Kim
      Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
    • Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases
      Yihao Liu, Fenghua Lai, Jianyan Long, Sui Peng, Haibo Wang, Qian Zhou, Bin Li, Lei Su, Lanxia Gan, Ying Shi, Weiming Lv, Yanbing Li, Karkeung Cheng, Haipeng Xiao
      International Journal of Cancer.2021; 148(5): 1106.     CrossRef
    • Diagnostic Performance of Ultrasound Computer-Aided Diagnosis Software Compared with That of Radiologists with Different Levels of Expertise for Thyroid Malignancy: A Multicenter Prospective Study
      Feng-Ying Ye, Guo-Rong Lyu, Shang-Qing Li, Jian-Hong You, Kang-Jian Wang, Ming-Li Cai, Qi-Chen Su
      Ultrasound in Medicine & Biology.2021; 47(1): 114.     CrossRef
    • Cancer frequency among the patients with myotonic dystrophy in the South Korean population using the national health insurance database
      Jin-Sung Park, Donghwi Park, Jin-Mo Park
      Journal of the Neurological Sciences.2021; 420: 117212.     CrossRef
    • Sarcopenic obesity and 10‐year cardiovascular disease risk scores in cancer survivors and non‐cancer participants using a nationwide survey
      Kayoung Lee
      European Journal of Cancer Care.2021;[Epub]     CrossRef
    • The role of postoperative radiotherapy after primary tumor resection in patients with de novo stage IV breast cancer
      Yeon Joo Kim, Su Ssan Kim, Seung Do Ahn, Jinhong Jung, Sei‐Hyun Ahn, Byung Ho Son, Jong Won Lee, Hee Jeong Kim, Beom Seok Ko, Sung‐Bae Kim, Kyung Hae Jung, Jin‐Hee Ahn, Jeong Eun Kim, Eun Kyung Choi
      Asia-Pacific Journal of Clinical Oncology.2021; 17(6): 495.     CrossRef
    • p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer
      Hyun Joo Bae, Sun Kyoung Kang, Woo Sun Kwon, Inhye Jeong, Sejung Park, Tae Soo Kim, Kyoo Hyun Kim, Hyunki Kim, Hei-Cheul Jeong, Hyun Cheol Chung, Sun Young Rha
      Biochemical Pharmacology.2021; 183: 114320.     CrossRef
    • Trends in End-of-Life Resource Utilization and Costs among Prostate Cancer Patients from 2006 to 2015: A Nationwide Population-Based Study
      Yun-Sok Ha, So-Young Kim, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Ji Youl Lee, Dong Jin Park, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, Kyungchan Min, Wun-Jae Kim, Seok Joong Yun, Jo
      The World Journal of Men's Health.2021; 39(1): 158.     CrossRef
    • Chronic Viral Hepatitis Is Associated with Colorectal Neoplasia: A Systematic Review and Meta-Analysis
      Seung Wook Hong, Won-Mook Choi, Ha Won Hwang, Dae Sung Kim, Jiyoung Yoon, Jin Wook Lee, Ju Hyun Shim, Dong-Hoon Yang, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
      Digestive Diseases and Sciences.2021; 66(11): 3715.     CrossRef
    • Translation and validation of the Korean version of the clinical frailty scale in older patients
      Ryoung-Eun Ko, Seong Mi Moon, Danbee Kang, Juhee Cho, Chi Ryang Chung, Yunhwan Lee, Yun Soo Hong, So Hee Lee, Jung Hee Lee, Gee Young Suh
      BMC Geriatrics.2021;[Epub]     CrossRef
    • Dehydroabietic acid inhibits the gastric cancer cell growth via induced apoptosis and cell cycle arrest
      Won-Jin Kim, Hyeon-Gu Kang, Seok-Jun Kim
      Molecular & Cellular Toxicology.2021; 17(2): 133.     CrossRef
    • Factors Associated with the Quality of Life of Patients with Cancer Undergoing Radiotherapy
      Ki Ho Seol, Su Hyun Bong, Dae Hun Kang, Jun Won Kim
      Psychiatry Investigation.2021; 18(1): 80.     CrossRef
    • Diagnostic value of combining tumor and inflammatory biomarkers in detecting common cancers in Korea
      Young Sun Kim, Kyung Nam Kang, Yong Sung Shin, Ji Eun Lee, Ji Young Jang, Chul Woo Kim
      Clinica Chimica Acta.2021; 516: 169.     CrossRef
    • Physical activity of Korean cancer survivors is associated with age and sex
      Jae Hyeon Park, Jung Soo Lee, Yoon Ho Ko, Yeo Hyung Kim
      The Korean Journal of Internal Medicine.2021; 36(Suppl 1): S225.     CrossRef
    • Risk factors of advanced metachronous neoplasms in surveillance after colon cancer resection
      Kwangwoo Nam, Jeong Eun Shin
      The Korean Journal of Internal Medicine.2021; 36(2): 305.     CrossRef
    • Sex difference in bowel preparation quality and colonoscopy time
      Young-Jae Hwang, Dong Woo Shin, Nayoung Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee
      The Korean Journal of Internal Medicine.2021; 36(2): 322.     CrossRef
    • The negative correlation between miR-140-3-p and Metadherin gene in estrogen and progesterone receptor positive–breast cancer
      Mai Mohamed Nabil, Maha Imam Ahmed, Muneera Al-Sheeha, Walaa Ahmed Yousry, Dalia Abdel Wahab Mohamed
      Gene Reports.2021; 23: 101068.     CrossRef
    • Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea
      Wonkyo Shin, Sanghee Lee, Myong Cheol Lim, Jipmin Jung, Hak Jin Kim, Hyunsoon Cho
      Cancer Medicine.2021; 10(6): 2045.     CrossRef
    • Adherence to follow-up examination after positive fecal occult blood test results affects colorectal cancer mortality: A Korea population-based cohort study
      Yu Jin Kim, Jeong-Im Shim, Eunjung Park, Minjoo Kang, Sinhee Kang, Jessie Lee, Ha Jin Tchoe, Kyeong Ae Kong, Duk Hwan Kim, Byung Chang Kim, Kui Son Choi, Chang Mo Moon
      Digestive and Liver Disease.2021; 53(5): 631.     CrossRef
    • Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer
      Eun Jung Jung, Ju-Yeon Kim, Jae-Myung Kim, Han Shin Lee, Seung-Jin Kwag, Ji-Ho Park, Taejin Park, Sang-Ho Jeong, Chi-Young Jeong, Young-Tae Ju, Young-Joon Lee, Soon-Chang Hong
      Medicine.2021; 100(11): e25000.     CrossRef
    • Diagnosis and Clinical Management of Esophageal Squamous Dysplasia
      Gwang Ha Kim
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(1): 4.     CrossRef
    • The Effects of Simultaneous Pulmonary Rehabilitation during Thoracic Radiotherapy in the Treatment of Malignant Diseases
      Myeong Geun Choi, Hyang Yi Lee, Si Yeol Song, Su Ssan Kim, Seung Hak Lee, Won Kim, Chang-Min Choi, Sei Won Lee
      Tuberculosis and Respiratory Diseases.2021; 84(2): 148.     CrossRef
    • Outcomes of extracorporeal membrane oxygenation in adults with active hematologic and nonhematologic malignancy
      Chul Park, Ui Won Ko, Ryoung‐Eun Ko, Soo Jin Na, Jeong Hoon Yang, Kyeongman Jeon, Gee Young Suh, Kiick Sung, Yang Hyun Cho
      Artificial Organs.2021;[Epub]     CrossRef
    • Comparison of CT Volumetry and RECIST to Predict the Treatment Response and Overall Survival in Gastric Cancer Liver Metastases
      Sung Hyun Yu, Seung Joon Choi, HeeYeon Noh, In seon Lee, So Hyun Park, Se Jong Kim
      Journal of the Korean Society of Radiology.2021; 82(4): 876.     CrossRef
    • Disparities in Liver Cancer Surveillance Among People With Disabilities
      Jae Youn Seo, Dong Wook Shin, Su Jong Yu, Jin Hyung Jung, Kyungdo Han, In Young Cho, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
      Journal of Clinical Gastroenterology.2021; 55(5): 439.     CrossRef
    • Population Attributable Fraction of Established Modifiable Risk Factors on Colorectal Cancer in Korea
      Sooyoung Cho, Aesun Shin
      Cancer Research and Treatment.2021; 53(2): 480.     CrossRef
    • Recent Trends in Opioid Prescription in Cancer Patients in Korea
      Jihyun Yoon, Hyeong-Seop Kim, Jae-Woo Lee, Joungyoun Kim, Hee-Taik Kang
      Korean Journal of Family Practice.2021; 11(2): 142.     CrossRef
    • Effect of Helicobacter pylori treatment on the long-term mortality in patients with type 2 diabetes
      Young-Il Kim, Young Ae Kim, Hak Jin Kim, Su-Hyun Kim, Yul Hwangbo, Jae Gyu Kim, Jae J. Kim, Il Ju Choi
      The Korean Journal of Internal Medicine.2021; 36(3): 584.     CrossRef
    • Worldwide trend in human papillomavirus–attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030
      Jie Wu, Fenqiang Xiao, Yang Zheng, Yushi Lin, Hong‐Liang Wang
      Cancer.2021; 127(17): 3172.     CrossRef
    • Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin
      Myunhee Lee, Woo‐Baek Chung, Ji‐eun Lee, Chan‐Seok Park, Woo‐Chan Park, Byung‐Joo Song, Ho‐Joong Youn
      Cancer Medicine.2021; 10(12): 3964.     CrossRef
    • Prospective Analysis of TERT Promoter Mutations in Papillary Thyroid Carcinoma at a Single Institution
      Yun-Suk Choi, Seong-Woon Choi, Jin-Wook Yi
      Journal of Clinical Medicine.2021; 10(10): 2179.     CrossRef
    • Disparities in prostate cancer diagnosis, treatment, and survival among men with disabilities: Retrospective cohort study in South Korea
      Dong Wook Shin, Jinsung Park, Kyoung Eun Yeob, Seok Jung Yoon, Soong-nang Jang, So Young Kim, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
      Disability and Health Journal.2021; 14(4): 101125.     CrossRef
    • Comprehensive Updates in the Role of Imaging for Multiple Myeloma Management Based on Recent International Guidelines
      Koeun Lee, Kyung Won Kim, Yousun Ko, Ho Young Park, Eun Jin Chae, Jeong Hyun Lee, Jin-Sook Ryu, Hye Won Chung
      Korean Journal of Radiology.2021; 22(9): 1497.     CrossRef
    • Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program
      Cam Nhung Bui, Seri Hong, Mina Suh, Jae Kwan Jun, Kyu Won Jung, Myong Cheol Lim, Kui Son Choi
      Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
    • Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea
      Young Ae Kim, Min Soo Yang, Minae Park, Min Gee Choi, So Young Kim, Yeon-Joo Kim
      Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
    • Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
      Yujun Park, An Na Seo, Jiwon Koh, Soo Kyoung Nam, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee
      OncoImmunology.2021;[Epub]     CrossRef
    • Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer
      Hyun Jin Roh, Hyung Joon Yoon, Dae Hoon Jeong, Tae Hwa Lee, Byung Su Kwon, Dong Soo Suh, Ki Hyung Kim
      Journal of Research in Medical Sciences.2021; 26(1): 48.     CrossRef
    • Descriptive epidemiology of cancer of unknown primary in South Korea, 1999–2017
      Yoo-Kyung Boo, Dayeon Park, Jiwon Lim, Hyun-Sook Lim, Young-Joo Won
      Cancer Epidemiology.2021; 74: 102000.     CrossRef
    • Survival and Death Causes in Thyroid Cancer in Taiwan: A Nationwide Case–Control Cohort Study
      Yu-Ling Lu, Shu-Fu Lin, Ming-Hsien Wu, Yi-Yin Lee, Pai-Wei Lee, Shang-Hung Chang, Yu-Tung Huang
      Cancers.2021; 13(16): 3955.     CrossRef
    • Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality
      Hye Yeon Koo, Su-Min Jeong, Mi Hee Cho, Sohyun Chun, Dong Wook Shin, Jinsung Park
      Scientific Reports.2021;[Epub]     CrossRef
    • Usefulness of artificial intelligence for predicting recurrence following surgery for pancreatic cancer: Retrospective cohort study
      Kwang-Sig Lee, Jin-Young Jang, Young-Dong Yu, Jin Seok Heo, Ho-Seong Han, Yoo-Seok Yoon, Chang Moo Kang, Ho Kyoung Hwang, Sunghwa Kang
      International Journal of Surgery.2021; 93: 106050.     CrossRef
    • Increasing Mortality in Korean Patients With Breast Cancer: High Mortality Rate in Elderly Breast Cancer Population Due to Suboptimal Treatment and Other Diseases
      Hyangsuk Choi, Hany Noh, Kwang-Min Kim, In-Jeong Cho, Seungtaek Lim, Airi Han
      Cancer Control.2021;[Epub]     CrossRef
    • Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial
      Kenshi Suzuki, Chang-Ki Min, Kihyun Kim, Je-Jung Lee, Hirohiko Shibayama, Po-Shen Ko, Shang-Yi Huang, Sin-Syue Li, Bifeng Ding, Monica Khurana, Shinsuke Iida
      International Journal of Hematology.2021; 114(6): 653.     CrossRef
    • Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer
      Sung Eun Oh, Mi Yun Oh, Ji Yeong An, Jun Ho Lee, Tae Sung Sohn, Jae Moon Bae, Min-Gew Choi, Kyoung-Mee Kim
      Pathology and Oncology Research.2021;[Epub]     CrossRef
    • Clinical impact of follow‐up imaging on mortality in Korean breast cancer patients: A national cohort study
      So‐Youn Jung, Young Ae Kim, Dong‐Eun Lee, Jungnam Joo, Joung Hwan Back, Sun‐Young Kong, Eun Sook Lee
      Cancer Medicine.2021; 10(18): 6480.     CrossRef
    • Development of Population-Based Cancer Indicators and a Measurement of Cancer Care Continuum Using a Modified Delphi Method
      Vasuki Rajaguru, Jieun Jang, JaeHyun Kim, JeoungA Kwon, Oyeon Cho, SeungYeun Chung, MiSun Ahn, JinHee Park, YoungJoo Won, KyuWon Jung, Jaeyong Shin, Mison Chun
      Cancers.2021; 13(19): 4826.     CrossRef
    • JAK2 regulates paclitaxel resistance in triple negative breast cancers
      Jongmin Han, Jihui Yun, Mingji Quan, Wonyoung Kang, Ji-Gwang Jung, Woohang Heo, Songbin Li, Kyu Jin Lee, Hye-Youn Son, Ju Hee Kim, Jaeyong Choi, Dong-Young Noh, Deukchae Na, Han Suk Ryu, Charles Lee, Jong-Il Kim, Hyeong-Gon Moon
      Journal of Molecular Medicine.2021; 99(12): 1783.     CrossRef
    • Evaluation of a Targeted Next-generation Sequencing Assay for BRCA Mutation Screening in Clinical Samples
      Man Jin Kim, Byeong Ju Song, Si Eun Kim, Chang Seon Lee, Ji-Eun Im, Ensel Oh, Keunsook Lee, Sung Im Cho, Kwang Joong Kim, Sung Sup Park, Moon-Woo Seong
      Laboratory Medicine Online.2021; 11(4): 283.     CrossRef
    • Tumor Size >5 cm and Harvested LNs <12 Are the Risk Factors for Recurrence in Stage I Colon and Rectal Cancer after Radical Resection
      Hye-Sol Jung, Seung-Bum Ryoo, Han-Ki Lim, Min Jung Kim, Sang Hui Moon, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park
      Cancers.2021; 13(21): 5294.     CrossRef
    • Prediction of hereditary nonpolyposis colorectal cancer using mRNA MSH2 quantitative and the correlation with nonmodifiable factor
      Tjahjadi Robert Tedjasaputra, Mochammad Hatta, Muh Nasrum Massi, Rosdiana Natzir, Agussalim Bukhari, Rina Masadah, Muh Lutfi Parewangi, Prihantono Prihantono, Rinda Nariswati, Vincent Tedjasaputra
      World Journal of Gastrointestinal Pathophysiology.2021; 12(6): 130.     CrossRef
    • Extended application of a CT-based artificial intelligence prognostication model in patients with primary lung cancer undergoing stereotactic ablative radiotherapy
      Hyungjin Kim, Joo Ho Lee, Hak Jae Kim, Chang Min Park, Hong-Gyun Wu, Jin Mo Goo
      Radiotherapy and Oncology.2021; 165: 166.     CrossRef
    • Prediction of hereditary nonpolyposis colorectal cancer using mRNA MSH2 quantitative and the correlation with nonmodifiable factor
      Tjahjadi Robert Tedjasaputra, Mochammad Hatta, Muh Nasrum Massi, Rosdiana Natzir, Agussalim Bukhari, Rina Masadah, Muh Lutfi Parewangi, Prihantono Prihantono, Rinda Nariswati, Vincent Tedjasaputra
      World Journal of Gastrointestinal Pathophysiology.2021; 12(6): 134.     CrossRef
    • Interplay of Threat, Efficacy, and Uncertainty in Cancer News Coverage: Analysis of News Content and Effects in South Korea
      Minsun Shim, Yong-Chan Kim, Keeho Park
      Asian Communication Research.2021; 18(3): 131.     CrossRef
    • Disparities in the Diagnosis, Treatment, and Survival Rate of Cervical Cancer among Women with and without Disabilities
      Jin Young Choi, Kyoung Eun Yeob, Seung Hwa Hong, So Young Kim, Eun-Hwan Jeong, Dong Wook Shin, Jong Heon Park, Gil-won Kang, Hak Soon Kim, Jong Hyock Park, Ichiro Kawachi
      Cancer Control.2021;[Epub]     CrossRef
    • Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy
      Kyungchan Min, Jae-Wook Chung, Yun-Sok Ha, Jun Nyung Lee, Bum Soo Kim, Hyun Tae Kim, Tae-Hwan Kim, Eun Sang Yoo, Tae Gyun Kwon, Sung Kwang Chung, Masatoshi Tanaka, Shin Egawa, Takahiro Kimura, Seock Hwan Choi
      The World Journal of Men's Health.2020; 38(2): 226.     CrossRef
    • Morning chronotype is a protective factor against chemotherapy-induced hot flashes in premenopausal women with breast cancer
      Kyung-Lak Son, Dooyoung Jung, Kwang-Min Lee, Heesung Hwang, JooYoung Lee, Tae-Yong Kim, Seock-Ah Im, Kyung-Hun Lee, David Spiegel, Bong-Jin Hahm
      Supportive Care in Cancer.2020; 28(3): 1351.     CrossRef
    • Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study
      Dong-Hoe Koo, Kyung-Do Han, Hong Joo Kim, Cheol-Young Park
      Acta Diabetologica.2020; 57(2): 197.     CrossRef
    • Coping style at diagnosis and its association with subsequent health-related quality of life in women with breast cancer: A 3-year follow-up study
      Young Up Cho, Bo Gyeong Lee, Soo Hyun Kim
      European Journal of Oncology Nursing.2020; 45: 101726.     CrossRef
    • Disease-Specific Mortality and Prevalence Trends in Korea, 2002–2015
      Yoonhee Shin, Bomi Park, Hye Ah Lee, Bohyun Park, Hyejin Han, Eun Jeong Choi, Nam-eun Kim, Hyesook Park
      Journal of Korean Medical Science.2020;[Epub]     CrossRef
    • The association between predicted inflammatory status and colorectal adenoma
      Sejin Kim, Sihan Song, Young Sun Kim, Sun Young Yang, Jung Eun Lee
      Scientific Reports.2020;[Epub]     CrossRef
    • Comparative Glycoproteomic Profiling of Human Body Fluid between Healthy Controls and Patients with Papillary Thyroid Carcinoma
      Yong Zhang, Wanjun Zhao, Yang Zhao, Yonghong Mao, Tao Su, Yi Zhong, Shisheng Wang, Rui Zhai, Jingqiu Cheng, Xiang Fang, Jingqiang Zhu, Hao Yang
      Journal of Proteome Research.2020; 19(7): 2539.     CrossRef
    • Nineteen-year trends in fermented food consumption and sodium intake from fermented foods for Korean adults from 1998 to 2016
      Sang Young Kim, Jeanne H Freeland-Graves, Hyun Ja Kim
      Public Health Nutrition.2020; 23(3): 515.     CrossRef
    • Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis
      Soheil Hassanipour, Hamed Delam, Morteza Arab-Zozani, Elham Abdzadeh, Seyyed Ali Hosseini, Hossein-Ali Nikbakht, Mahdi Malakoutikhah, Mohammad Taghi Ashoobi, Mohammad Fathalipour, Hamid Salehiniya, Shirin Riahi
      Annals of Global Health.2020; 86(1): 2.     CrossRef
    • Effect of Digital Mammography for Breast Cancer Screening: A Comparative Study of More than 8 Million Korean Women
      Seri Hong, Soo Yeon Song, Boyoung Park, Mina Suh, Kui Son Choi, Seung Eun Jung, Min Jung Kim, Eun Hye Lee, Chan Wha Lee, Jae Kwan Jun
      Radiology.2020; 294(2): 247.     CrossRef
    • Practice patterns of multidisciplinary team meetings in Korean cancer care and patient satisfaction with this approach
      Chi Hoon Maeng, Hee Kyung Ahn, Sung Yong Oh, Seungtaek Lim, Bong-Seog Kim, Do Yeun Kim
      The Korean Journal of Internal Medicine.2020; 35(1): 205.     CrossRef
    • Breast cancer screening disparities between women with and without disabilities: A national database study in South Korea
      Dong Wook Shin, Jonghan Yu, Juhee Cho, Se Kyung Lee, Jin Hyung Jung, Kyungdo Han, So Young Kim, Jung Eun Yoo, Kyoung Eun Yeob, Yeon Yong Kim, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
      Cancer.2020; 126(7): 1522.     CrossRef
    • Factors influencing supportive care needs of multiple myeloma patients treated with chemotherapy
      Yoo-Rin Cho, Yang-Sook Yoo
      Supportive Care in Cancer.2020; 28(4): 1783.     CrossRef
    • Disparities in gastric cancer screening among people with disabilities: a national registry-linkage study in South Korea
      YoungJee Kim, Dong Wook Shin, Hyoung Woo Kim, Jin Hyung Jung, Kyungdo Han, In Young Cho, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
      Gastric Cancer.2020; 23(3): 497.     CrossRef
    • Identification of Korean cancer survivors’ unmet needs and desired psychosocial assistance: A focus group study
      Joo Young Kim, Mison Chun, Sang-Won Kim, Joonsup Song, Rosemary Frey
      PLOS ONE.2020; 15(1): e0228054.     CrossRef
    • Prospective evaluation of clinical symptoms of chemotherapy‐induced oral mucositis in adult patients with acute leukemia: A preliminary study
      Yeon‐Hee Lee, Junshik Hong, Inho Kim, Youngnim Choi, Hee‐Kyung Park
      Clinical and Experimental Dental Research.2020; 6(1): 90.     CrossRef
    • Analysis of Prognosis according to Type of Health Insurance in Five Major Gastrointestinal Cancer Patients in Public Hospitals: Single-institution Retrospective Study
      Dong Seok Lee, Jaekyung Lee, Ji Won Kim, Kook Lae Lee, Byeong Gwan Kim, Su Hwan Kim, Yong Jin Jung
      The Korean Journal of Gastroenterology.2020; 75(1): 17.     CrossRef
    • Prognostic Performance of Preoperative Staging: Assessed by Using Multidetector Computed Tomography—Between the New Clinical Classification and the Pathological Classification in the Eighth American Joint Committee on Cancer Classification for Gastric Car
      Oh Jeong, Mi Ran Jung, Ji Hoon Kang, Seong Yeob Ryu
      Annals of Surgical Oncology.2020; 27(2): 545.     CrossRef
    • Endoscopic submucosal dissection for superficial esophageal neoplasms in elderly patients: A single‐center, large‐scale, retrospective study
      Jin Hee Noh, Eun Jeong Gong, Do Hoon Kim, Hee Kyong Na, Ji Yong Ahn, Jeong Hoon Lee, Kee Wook Jung, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon‐Yong Jung
      Geriatrics & Gerontology International.2020; 20(5): 430.     CrossRef
    • National screening programs for cervical cancer in Asian countries
      Eiko Saitoh Aoki, Rutie Yin, Kemin Li, Neerja Bhatla, Seema Singhal, Dwiana Ocviyanti, Kumiko Saika, Mina Suh, Miseon Kim, Wichai Termrungruanglert
      Journal of Gynecologic Oncology.2020;[Epub]     CrossRef
    • Trends in Influenza Vaccination Coverage Rates among Korean Cancer Survivors: Analysis of the Korea National Health and Nutrition Examination Survey III–VI
      Ye-Seul Kim, Jae-woo Lee, Hee-Taik Kang, Yonghwan Kim, Hyo-Sun You
      Korean Journal of Family Medicine.2020; 41(1): 45.     CrossRef
    • Descriptive analysis of prevalence and medical expenses of cancer, cardio-cerebrovascular disease, psychiatric disease, and musculoskeletal disease in Korean firefighters
      Jeehee Min, Yangwoo Kim, Hye Sim Kim, Jiyoung Han, Inah Kim, Jaechul Song, Sang-Baek Koh, Tae-Won Jang
      Annals of Occupational and Environmental Medicine.2020;[Epub]     CrossRef
    • Dietary mercury intake and colorectal cancer risk: A case-control study
      Hyejin Kim, Jeonghee Lee, Hae Dong Woo, Dong Woo Kim, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
      Clinical Nutrition.2020; 39(7): 2106.     CrossRef
    • The association of physical function and quality of life on physical activity for non-small cell lung cancer survivors
      Ji Sung Yoo, Hee Chul Yang, Jong Mog Lee, Moon Soo Kim, Eun-Cheol Park, Seung Hyun Chung
      Supportive Care in Cancer.2020; 28(10): 4847.     CrossRef
    • Evaluation of an optimal cutoff of parathyroid venous sampling gradient for localizing primary hyperparathyroidism
      Jooyeon Lee, Namki Hong, Byung Moon Kim, Dong Joon Kim, Mijin Yun, Jong Ju Jeong, Yumie Rhee
      Journal of Bone and Mineral Metabolism.2020; 38(4): 570.     CrossRef
    • Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Using Preoperative Clinicopathologic Factors
      Naru Kim, In Woong Han, Youngju Ryu, Dae Wook Hwang, Jin Seok Heo, Dong Wook Choi, Sang Hyun Shin
      Cancers.2020; 12(1): 137.     CrossRef
    • Unexpected Para-aortic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: a Contraindication to Resection?
      Ji Su Kim, Ho Kyoung Hwang, Woo Jung Lee, Chang Moo Kang
      Journal of Gastrointestinal Surgery.2020; 24(12): 2789.     CrossRef
    • Comparison of liquid-based cytology with conventional smear cytology for EUS-guided FNA of solid pancreatic masses: a prospective randomized noninferiority study
      Jung Won Chun, Kyoungbun Lee, Sang Hyub Lee, Haeryoung Kim, Min Su You, Yoon Jung Hwang, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
      Gastrointestinal Endoscopy.2020; 91(4): 837.     CrossRef
    • Thyroid cancer: incidence and mortality trends in China, 2005–2015
      Junyi Wang, Fangfang Yu, Yanna Shang, Zhiguang Ping, Li Liu
      Endocrine.2020; 68(1): 163.     CrossRef
    • High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
      Tae-Wook Kong, Miseon Kim, Young-Han Kim, Yong Beom Kim, Jayeon Kim, Jae-Weon Kim, Mi Hye Park, Joo Hyun Park, Jeong Ho Rhee, Myong Cheol Lim, Joon-Seok Hong
      Journal of Gynecologic Oncology.2020;[Epub]     CrossRef
    • Validation of the Eighth Edition Clinical T Categorization System for Clinical Stage IA, Resected Lung Adenocarcinomas: Prognostic Implications of the Ground-Glass Opacity Component
      Hyungjin Kim, Jin Mo Goo, Young Tae Kim, Chang Min Park
      Journal of Thoracic Oncology.2020; 15(4): 580.     CrossRef
    • The Effect of Disability on the Diagnosis and Treatment of Multiple Myeloma in Korea: A National Cohort Study
      Jihyun Kwon, So Young Kim, Kyoung Eun Yeob, Hye Sook Han, Ki Hyeong Lee, Dong Wook Shin, Yeon-Yong Kim, Jong Heon Park, Jong Hyock Park
      Cancer Research and Treatment.2020; 52(1): 1.     CrossRef
    • Trajectories of health-related quality of life in breast cancer patients
      Jin-Hee Park, Yong Sik Jung, Ji Young Kim, Yujung Jo, Sun Hyoung Bae
      Supportive Care in Cancer.2020; 28(7): 3381.     CrossRef
    • Family History of Gastric Cancer and Helicobacter pylori Treatment
      Il Ju Choi, Chan Gyoo Kim, Jong Yeul Lee, Young-Il Kim, Myeong-Cherl Kook, Boram Park, Jungnam Joo
      New England Journal of Medicine.2020; 382(5): 427.     CrossRef
    • Long-term Oncologic Outcome and Its Relevant Factors in Anal Cancer in Korea: A Nationwide Data Analysis
      Hyuk Hur, Kyu-Won Jung, Byung-Woo Kim, Chang-Mo Oh, Young-Joo Won, Jae Hwan Oh, Nam Kyu Kim
      Annals of Coloproctology.2020; 36(1): 35.     CrossRef
    • Diagnostic accuracy of administrative database for bile duct cancer by ICD-10 code in a tertiary institute in Korea
      Young-Jae Hwang, Seon Mee Park, Soomin Ahn, Jongchan Lee, Young Soo Park, Nayoung Kim
      Hepatobiliary & Pancreatic Diseases International.2020; 19(6): 575.     CrossRef
    • Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells
      Sun Tae Hwang, Jae-Young Um, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Acharan S. Narula, Ojas A. Namjoshi, Bruce E. Blough, Kwang Seok Ahn
      Molecules.2020; 25(6): 1320.     CrossRef
    • Epstein–Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas
      Chan Jin Yoon, Mee Soo Chang, Dong Ha Kim, Won Kim, Bo Kyung Koo, Sung-Cheol Yun, Sung Han Kim, Yang Soo Kim, Jun Hee Woo
      Gastric Cancer.2020; 23(5): 780.     CrossRef
    • Korean National Lung Cancer Screening
      Seung Hun Jang
      The Korean Journal of Medicine.2020; 95(2): 95.     CrossRef
    • Minimally invasive complete mesocolic excision for right colon cancer
      Hyunmi Park, Tae‐Hoon Lee, Seon‐Hahn Kim
      Annals of Gastroenterological Surgery.2020; 4(3): 234.     CrossRef
    • Association Between lncRNA HULC rs7763881 Polymorphism and Gastric Cancer Risk


      Jang Hee Hong, Eun-Heui Jin, In Ae Chang, Hyojin Kang, Sang-Il Lee, Jae Kyu Sung
      Pharmacogenomics and Personalized Medicine.2020; Volume 13: 121.     CrossRef
    • Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients
      Hye-Kyung Jung, Chung Hyun Tae, Hye-Ah Lee, Hyuk Lee, Kee Don Choi, Jun Chul Park, Joong Goo Kwon, Yoon Jin Choi, Su Jin Hong, Jaekyu Sung, Woo Chul Chung, Ki Bae Kim, Seung Young Kim, Kyung Ho Song, Kyung Sik Park, Seong Woo Jeon, Byung-Wook Kim, Han Seu
      PLOS ONE.2020; 15(4): e0231456.     CrossRef
    • Impact of Onset of Psychiatric Disorders and Psychiatric Treatment on Mortality Among Patients with Cancer
      Sang Ah Lee, Chung Mo Nam, Young Hoon Kim, Tae Hyun Kim, Sung-In Jang, Eun-Cheol Park
      The Oncologist.2020; 25(4): e733.     CrossRef
    • Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer
      Jeong Il Yu, Hee Chul Park, Jeeyun Lee, Changhoon Choi, Won Ki Kang, Se Hoon Park, Seung Tae Kim, Tae Sung Sohn, Jun Ho Lee, Ji Yeong An, Min Gew Choi, Jae Moon Bae, Kyoung-Mee Kim, Heewon Han, Kyunga Kim, Sung Kim, Do Hoon Lim
      Cancers.2020; 12(4): 943.     CrossRef
    • Comparison of subjective quality of life after endoscopic submucosal resection or surgery for early gastric cancer
      Chung Hyun Tae, Ki-Nam Shim, Byung-Wook Kim, Jie-Hyun Kim, Su Jin Hong, Gwang Ho Baik, Hyun Joo Song, Yong Sung Kim, Seung-Ho Jang, Hye-Kyung Jung
      Scientific Reports.2020;[Epub]     CrossRef
    • Early Recurrence of Breast Cancer after the Primary Treatment: Analysis of Clinicopathological and Radiological Predictive Factors
      Sun Geun Yun, Yeong Yi An, Sung Hun Kim, Bong Joo Kang
      Journal of the Korean Society of Radiology.2020; 81(2): 395.     CrossRef
    • Establishment and characterization of 18 human colorectal cancer cell lines
      Soon-Chan Kim, Hyun-Soo Kim, Jae Hyeon Kim, Nahyun Jeong, Young-Kyoung Shin, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Ja-Lok Ku
      Scientific Reports.2020;[Epub]     CrossRef
    • Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
      Melina Arnold, Jin Young Park, M Constanza Camargo, Nuno Lunet, David Forman, Isabelle Soerjomataram
      Gut.2020; 69(5): 823.     CrossRef
    • Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases
      Sang-A Kim, Ji-Won Kim, Koung Jin Suh, Won Chang, Jin Won Kim, Heung-Kwon Oh, Jai Young Cho, Duck-Woo Kim, Sukki Cho, Jee Hyun Kim, Kwhanmien Kim, Sung-Bum Kang, Sanghoon Jheon, Keun-Wook Lee
      Journal of Cancer Research and Clinical Oncology.2020; 146(9): 2399.     CrossRef
    • Prognostic Factors of Disease Recurrence in Breast Cancer Using Quantitative and Qualitative Magnetic Resonance Imaging (MRI) Parameters
      Jeongmin Lee, Sung Hun Kim, Bong Joo Kang
      Scientific Reports.2020;[Epub]     CrossRef
    • Recent Advances in Combinatorial Cancer Therapy Via Multifunctionalized Gold Nanoparticles
      Touqeer Ahmad, Rizwana Sarwar, Ayesha Iqbal, Uzma Bashir, Umar Farooq, Sobia Ahsan Halim, Ajmal Khan, Ahmed Al-Harrasi
      Nanomedicine.2020; 15(12): 1221.     CrossRef
    • Sex difference in incidence of gastric cancer: an international comparative study based on the Global Burden of Disease Study 2017
      Lixia Lou, Linyan Wang, Yaoyi Zhang, Guofeng Chen, Lele Lin, Xiaoli Jin, Yi Huang, Jian Chen
      BMJ Open.2020; 10(1): e033323.     CrossRef
    • Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging?
      Huapyong Kang, Seung-seob Kim, Min Je Sung, Jung Hyun Jo, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Mi-Suk Park, Seungmin Bang
      Pancreatology.2020; 20(5): 952.     CrossRef
    • Differences in Factors Affecting the Quality of Life Over Time After the Gastrectomy in Patients With Stage I Gastric Cancer
      Kyung Eun Lee, Kyung Hee Lim
      Gastroenterology Nursing.2020; 43(3): 241.     CrossRef
    • Age-Standardized Breast Cancer Detection Rates of Breast Cancer Screening Program by Age Group in Korea; Comparison with Age-Standardized Incidence Rates from the Korea Central Cancer Registry
      Miye Kim, Hyeongsu Kim, Heejung Choi, MiSeon Son, Kun-Sei Lee, Tae-Hwa Han, Sollip Kim
      Healthcare.2020; 8(2): 132.     CrossRef
    • Robotics Total Mesorectal Excision Up To the Minute
      Homoud Alawfi, Ho Seung Kim, Seung Yoon Yang, Nam Kyu Kim
      Indian Journal of Surgical Oncology.2020; 11(4): 552.     CrossRef
    • Comparisons of remnant primary, residual, and recurrent gastric cancer and applicability of the 8th AJCC TNM classification for remnant gastric cancer staging
      Sung Eun Oh, Ji Yeong An, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Jae Moon Bae
      European Journal of Surgical Oncology.2020; 46(12): 2236.     CrossRef
    • The Incidence and Management Trends of Metastatic Spinal Tumors in South Korea
      Sung Hoon Choi, Ja Wook Koo, DaeHyun Choe, Chang-Nam Kang
      Spine.2020; 45(14): E856.     CrossRef
    • The major effects of health-related quality of life on 5-year survival prediction among lung cancer survivors: applications of machine learning
      Jin-ah Sim, Young Ae Kim, Ju Han Kim, Jong Mog Lee, Moon Soo Kim, Young Mog Shim, Jae Ill Zo, Young Ho Yun
      Scientific Reports.2020;[Epub]     CrossRef
    • Vitamin D Status and Gastric Cancer: A Cross-Sectional Study in Koreans
      Jung Hyun Kwak, Jean Kyung Paik
      Nutrients.2020; 12(7): 2004.     CrossRef
    • Diagnostic Value of Circulating miR-202 in Early-Stage Breast Cancer in South Korea
      Jungho Kim, Sunyoung Park, Dasom Hwang, Seung Il Kim, Hyeyoung Lee
      Medicina.2020; 56(7): 340.     CrossRef
    • Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer
      Jee Suk Chang, Nalee Kim, Ji-Ye Kim, Sung-Im Do, Yeona Cho, Hyun-Soo Kim, Yong Bae Kim
      Journal of Gynecologic Oncology.2020;[Epub]     CrossRef
    • Analysis of Tumor Size between Imaging of Preoperative Ultrasound, MRI and Pathologic Measurements in Early Breast Carcinoma
      Eun Hyeok Kim, Chan Gyun Park, Eun Hye Choi, Ye Jeong Kim, Mi Jin Kim, Kyu Dam Han, Young Sam Park, Cheol Seung Kim, Kyun Hui No, Eun Ae Yu, Gyeong Gyun Na
      Journal of Breast Disease.2020; 8(1): 19.     CrossRef
    • Operation Experiences of Women with Breast Cancer
      Hyeon-Young Kim, Sun Hwa Shin
      Journal of Korean Academy of Fundamentals of Nursing.2020; 27(2): 129.     CrossRef
    • Public Attitudes towards Cancer Survivors among Korean Adults
      Su Yeon Kye, Hyun Jeong Lee, Yeonseung Lee, Young Ae Kim
      Cancer Research and Treatment.2020; 52(3): 722.     CrossRef
    • Cancer Mortality Trends in Spain (2000–2016): Differences between Immigrant and Native Populations
      Adriana Oliva-Arocas, Pamela Pereyra-Zamora, José M. Copete, Andreu Nolasco
      International Journal of Environmental Research and Public Health.2020; 17(14): 5127.     CrossRef
    • The Health Impact of, and access to, New Drugs in Korea
      Frank R. Lichtenberg
      East Asian Economic Review.2020; 24(2): 127.     CrossRef
    • Estimating the disease burden of lung cancer attributable to residential radon exposure in Korea during 2006–2015: A socio-economic approach
      Juhwan Noh, Heeseon Jang, Jaelim Cho, Dae Ryong Kang, Tae Hyun Kim, Dong Chun Shin, Changsoo Kim
      Science of The Total Environment.2020; 749: 141573.     CrossRef
    • Squamous cell carcinoma of head and neck: what internists should know
      Kyungsuk Jung, Manpreet Narwal, Seon Young Min, Bhumsuk Keam, Hyunseok Kang
      The Korean Journal of Internal Medicine.2020; 35(5): 1031.     CrossRef
    • FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
      Changhoon Yoo, Inhwan Hwang, Tae Jun Song, Sang Soo Lee, Jae Ho Jeong, Do Hyun Park, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jae Ho Byun, Jin-hong Park, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Heung-Moon Chang, Kyu-pyo Kim, Song Che
      Therapeutic Advances in Medical Oncology.2020;[Epub]     CrossRef
    • Rhus verniciflua Stokes extract suppresses migration and invasion in human gastric adenocarcinoma AGS cells
      Hyun Sook Lee, Jae In Jung, Kyeong-Hee Kim, Sang Jae Park, Eun Ji Kim
      Nutrition Research and Practice.2020; 14(5): 463.     CrossRef
    • Mediterranean Diet and Naltrexone/Bupropion Treatment for Weight Loss in Overweight and Obese Breast Cancer Survivors and Non-Cancer Participants: A Pilot Randomized Controlled Trial


      A-Ra Cho, Won-Jun Choi, Yu-Jin Kwon, Hye Sun Lee, Sung Gwe Ahn, Ji-Won Lee
      Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 3325.     CrossRef
    • Ultrasonographic evaluation of chronic shoulder pain after breast cancer surgery: single center, cross-sectional study
      Jung Hun Kim, Se Hee Kim, Hae-Rim Kim, Sang-Heon Lee, So Young Yoon, Jung-Hyun Yang, Young Bum Yoo, Kyoung Sik Park, Sang Eun Nam, Semie Hong, Hong Ki Min
      Scientific Reports.2020;[Epub]     CrossRef
    • Disparities in the Diagnosis and Treatment of Gastric Cancer in Relation to Disabilities
      Hyoung Woo Kim, Dong Wook Shin, Kyoung Eun Yeob, In Young Cho, So Young Kim, Seon Mee Park, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
      Clinical and Translational Gastroenterology.2020; 11(10): e00242.     CrossRef
    • Efficacy of modified radical prostatectomy technique for recovery of urinary incontinence in high-grade prostate cancer
      Jae W. Chung, Sang W. Kim, Ho W. Kang, Yun S. Ha, Seock H. Choi, Jun N. Lee, Bum S. Kim, Hyun T. Kim, Tae H. Kim, Ghil S. Yoon, Tae G. Kwon, Sung K. Chung, Eun S. Yoo
      Minerva Urologica e Nefrologica.2020;[Epub]     CrossRef
    • Personality Types as Predictors of Breast Cancer Screening Compliance in Korean Patients: A Mixed-Method Approach
      Kyungmin Kim, Eunhee Sohn, Hyo-Deog Rim, Seoyoung Jang, Jungmin Woo
      Psychiatry Investigation.2020; 17(11): 1079.     CrossRef
    • Efficacy of the CDK7 Inhibitor on EMT-Associated Resistance to 3rd Generation EGFR-TKIs in Non-Small Cell Lung Cancer Cell Lines
      Wonjun Ji, Yun Jung Choi, Myoung-Hee Kang, Ki Jung Sung, Dong Ha Kim, Sangyong Jung, Chang-Min Choi, Jae Cheol Lee, Jin Kyung Rho
      Cells.2020; 9(12): 2596.     CrossRef
    • Long-term oncological outcomes of laparoscopic gastrectomy for grossly early gastric cancer-mimicking advanced gastric cancer
      Sung Eun Oh, Ji Yeong An, Min-Gew Choi, Tae Sung Sohn, Jae Moon Bae, Jun Ho Lee
      Medicine.2020; 99(49): e23441.     CrossRef
    • Whole-Slide Image Analysis Reveals Quantitative Landscape of Tumor–Immune Microenvironment in Colorectal Cancers
      Seung-Yeon Yoo, Hye Eun Park, Jung Ho Kim, Xianyu Wen, Seorin Jeong, Nam-Yun Cho, Hwang Gwan Gwon, Kwangsoo Kim, Hye Seung Lee, Seung-Yong Jeong, Kyu Joo Park, Sae-Won Han, Tae-You Kim, Jeong Mo Bae, Gyeong Hoon Kang
      Clinical Cancer Research.2020; 26(4): 870.     CrossRef
    • Obesity Has a Stronger Relationship with Colorectal Cancer in Postmenopausal Women than Premenopausal Women
      Ji Won Chang, Dong Wook Shin, Kyung Do Han, Keun Hye Jeon, Jung Eun Yoo, In Young Cho, Yun Jin Choi, Jung Yong Hong
      Cancer Epidemiology, Biomarkers & Prevention.2020; 29(11): 2277.     CrossRef
    • Sex Difference and Smoking Effect of Lung Cancer Incidence in Asian Population
      Boyoung Park, Yeol Kim, Jaeho Lee, Nayoung Lee, Seung Hun Jang
      Cancers.2020; 13(1): 113.     CrossRef
    • The Current Situation and Future Trend of Leukemia Mortality by Sex and Area in China
      Baojing Li, Hong Tang, Zilu Cheng, Yuxiao Zhang, Hao Xiang
      Frontiers in Public Health.2020;[Epub]     CrossRef
    • A New Strategy for Elimination of Human Paplloma Virus-related Disease after Human Papillomavirus Vaccines Introduction
      Yoo-Jin Park, Tae-Hee Kim, Hae-Hyeog Lee, Jun-Mo Kim
      Urogenital Tract Infection.2020; 15(3): 63.     CrossRef
    • Overview of Malignancy in Pregnancy
      Yung-Taek Ouh, Geum Joon Cho, Sunghun Na
      Perinatology.2020; 31(4): 161.     CrossRef
    • Comparison of survival outcomes according of patients with metastatic gastric cancer receiving trastuzumab with systemic chemotherapy
      Gi-Young Ha, Sung-Hyun Yang, Hye-Jin Kang, Hyo-Lak Lee, Jin Kim, Yun-Ju Kim, Hang-Jong Yu, Jong-Inn Lee, Sung-Ho Jin
      Korean Journal of Clinical Oncology.2020; 16(2): 63.     CrossRef
    • Association between perception of care coordination and health outcomes in Korean cancer survivors
      Jinyoung Shin, Dong Wook Shin, Jungkwon Lee, Ji Hye Hwang, Jung Eun Yoo, Hyeonyoung Ko, Yun-Mi Song
      Health and Quality of Life Outcomes.2020;[Epub]     CrossRef
    • The Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression
      Jaebeom Cho, Hyo-Jong Lee, Su Jung Hwang, Hye-Young Min, Han Na Kang, A-Young Park, Seung Yeob Hyun, Jeong Yeon Sim, Ho Jin Lee, Hyun-Ji Jang, Young-Ah Suh, Sungyoul Hong, Young Kee Shin, Hye Ryun Kim, Ho-Young Lee
      Cancer Research.2020; 80(11): 2257.     CrossRef
    • Tumor Identification in Colorectal Histology Images Using a Convolutional Neural Network
      Hongjun Yoon, Joohyung Lee, Ji Eun Oh, Hong Rae Kim, Seonhye Lee, Hee Jin Chang, Dae Kyung Sohn
      Journal of Digital Imaging.2019; 32(1): 131.     CrossRef
    • Significance of 18F-FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non–small-cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy
      Eunji Kim, Hong-Gyun Wu, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Jin Chul Paeng, Hak Jae Kim, Ji Hyun Chang
      Clinical Lung Cancer.2019; 20(1): e9.     CrossRef
    • Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores
      Inhwan Hwang, Jihoon Kang, Hei Nga Natalie Ip, Jae Ho Jeong, Kyu-pyo Kim, Heung-Moon Chang, Changhoon Yoo, Baek-Yeol Ryoo
      Investigational New Drugs.2019; 37(3): 584.     CrossRef
    • Pathologic differential diagnosis of metastatic carcinoma in the liver
      Jeong Hwan Park, Jung Ho Kim
      Clinical and Molecular Hepatology.2019; 25(1): 12.     CrossRef
    • Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility
      Seon Woo Lee, Do Youn Park, Mi-Young Kim, Changwon Kang
      Gastric Cancer.2019; 22(3): 640.     CrossRef
    • Association between dietary cadmium intake and early gastric cancer risk in a Korean population: a case–control study
      Hyejin Kim, Jeonghee Lee, Hae Dong Woo, Dong Woo Kim, Il Ju Choi, Young-Il Kim, Jeongseon Kim
      European Journal of Nutrition.2019; 58(8): 3255.     CrossRef
    • High Receipt of Statins Reduces the Risk of Lung Cancer in Current Smokers With Hypercholesterolemia: The National Health Insurance Service–Health Screening Cohort
      Yu-Jin Kwon, Na-Young You, Jae-Woo Lee, Joungyoun Kim, Hee-Taik Kang
      Clinical Lung Cancer.2019; 20(2): e177.     CrossRef
    • Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015
      Myong Cheol Lim, Young-Joo Won, Mun Jung Ko, Miseon Kim, Seung-Hyuk Shim, Dong Hoon Suh, Jae-Weon Kim
      Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
    • Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer
      Su Hyun Chae, Seung-Hyuk Shim, Sun Joo Lee, Ji Young Lee, Soo-Nyung Kim, Soon-Beom Kang
      International Journal of Gynecological Cancer.2019; 29(1): 77.     CrossRef
    • The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis
      Hwajeong Lee
      Yonsei Medical Journal.2019; 60(2): 223.     CrossRef
    • Clinical Applications of Automated Breast Ultrasound: Screening for Breast Cancer
      Sun Mi Kim, Bo La Yun, Mijung Jang
      Journal of the Korean Society of Radiology.2019; 80(1): 32.     CrossRef
    • Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells
      Jong Won Lee, Jae Sook Sung, Young Soo Park, Seok Chung, Yeul Hong Kim
      Gastric Cancer.2019; 22(5): 967.     CrossRef
    • Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study
      Yoon Park, Tae-Jin Kim, Chang-Sun Hwang, Chi Heum Cho, Dae Hoon Jeong, Seok Ju Seong, Jae-Kwan Lee, Sooyoung Hur, Mee-Kyung Kee, Jaehyun Seong, Moran Ki
      Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
    • Correlation of Thyroid Transcription Factor-1 Expression with EGFR Mutations in Non-Small-Cell Lung Cancer: A Meta-Analysis
      Hyeong Su Kim, Jung Han Kim, Boram Han, Dae Ro Choi
      Medicina.2019; 55(2): 41.     CrossRef
    • Trends and Outcomes of Non-compliance with Treatment for Gastric Cancer in Korea over the 16 years from 1999 to 2015
      Bang Wool Eom, Kyu-Won Jung, Young-Joo Won, Young-Woo Kim
      Journal of Gastric Cancer.2019; 19(1): 92.     CrossRef
    • Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node–Positive Gastric Cancer Treated with Different Adjuvant Protocols
      Jeong Il Yu, Do Hoon Lim, Jeeyun Lee, Won Ki Kang, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Seung Tae Kim, Su Jin Lee, Sung Kim, Tae Sung Sohn, Jun Ho Lee, Ji Yeong An, Min Gew Choi, Jae Moon Bae, Heejin Yoo, Kyunga Kim
      Cancer Research and Treatment.2019; 51(3): 876.     CrossRef
    • Thyroid cancer risks among medical radiation workers in South Korea, 1996–2015
      Won Jin Lee, Dale L. Preston, Eun Shil Cha, Seulki Ko, Hyeyeun Lim
      Environmental Health.2019;[Epub]     CrossRef
    • The role of surgical resection before palliative chemotherapy in advanced gastric cancer
      Yong Won Choi, Mi Sun Ahn, Geum Sook Jeong, Hyun Woo Lee, Seong Hyun Jeong, Seok Yun Kang, Joon Seong Park, Jin-Hyuk Choi, Sang-Yong Son, Hoon Hur, Sang-Uk Han, Seung Soo Sheen
      Scientific Reports.2019;[Epub]     CrossRef
    • How to Achieve a Higher Pathologic Complete Response in Patients With Locally Advanced Rectal Cancer Who Receive Preoperative Chemoradiation Therapy
      Suk-Hwan Lee
      Annals of Coloproctology.2019; 35(1): 3.     CrossRef
    • Cancer Survivors and Returning to Work Perspectives from Occupational Health Physicians in Korea
      Hye Young Shim, Choong Won Lee, Eun Seung Yu, Bo Young Park, Eun Joo Yang
      Journal of Korean Medical Science.2019;[Epub]     CrossRef
    • Risk Factors for Delayed Isolation of Patients with Active Pulmonary Tuberculosis in an Acute-care Hospital
      Jaijun Han, Bo Da Nam, Se Yoon Park, Jebyung Park, Eunyoung Lee, Eun Jung Lee, Jung Hwa Hwang, Tae Hyong Kim
      Scientific Reports.2019;[Epub]     CrossRef
    • Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis
      Yoon Jin Cha, Eun Jung Park, Seung Hyuk Baik, Kang Young Lee, Jeonghyun Kang, Aamir Ahmad
      PLOS ONE.2019; 14(3): e0214415.     CrossRef
    • Trends and Updated Statistics of Lung Cancer in Korea
      Chan Kwon Park, Seung Joon Kim
      Tuberculosis and Respiratory Diseases.2019; 82(2): 175.     CrossRef
    • Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach

      Journal of Gastric Cancer.2019; 19(1): 1.     CrossRef
    • The prevalence of histologic atrophy and intestinal metaplasia in the corpus has decreased over 15 years in females in the Korean population
      Young Jae Kwon, Nayoung Kim, Sung Min Baek, Hye Seung Lee, Jaebong Lee, Young Jae Hwang, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Jin‐Wook Kim, Dong Ho Lee
      Helicobacter.2019;[Epub]     CrossRef
    • For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
      Won Tae Kim, Seok Joong Yun, Wun-Jae Kim
      International Neurourology Journal.2019; 23(1): 5.     CrossRef
    • Prediagnostic Smoking and Alcohol Drinking and Gastric Cancer Survival: A Korean Prospective Cohort Study
      Shin Ah Kim, Bo Youl Choi, Kyu Sang Song, Chan Hyuk Park, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Hyun Ja Kim
      The Korean Journal of Gastroenterology.2019; 73(3): 141.     CrossRef
    • Role of Upper Gastrointestinal Endoscopy in Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy
      Jin Suk Kang, Sun Hee Lee, Shinwon Lee, Gwang Ha Kim, Young Joo Park, In Sub Han, Jeong Eun Lee, Soon Ok Lee, Chisook Moon
      Infection & Chemotherapy.2019; 51(1): 35.     CrossRef
    • Lycopene Inhibits Reactive Oxygen Species-Mediated NF-κB Signaling and Induces Apoptosis in Pancreatic Cancer Cells
      Yoonseon Jeong, Joo Weon Lim, Hyeyoung Kim
      Nutrients.2019; 11(4): 762.     CrossRef
    • ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis
      Sunyoung Park, Suji Lee, Jungho Kim, Geehyuk Kim, Kwang Hwa Park, Tae Ue Kim, Dawn Chung, Hyeyoung Lee, Hiromu Suzuki
      PLOS ONE.2019; 14(4): e0214867.     CrossRef
    • A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy
      Jung Ho Kim, Jinnam Kim, Woon Ji Lee, Hye Seong, Heun Choi, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Taeil Son, Hyoung-Il Kim, Sang Hoon Han, Jun Yong Choi, Joon-Sup Yeom, Woo Jin Hyung, Young Goo Song, Sung Hoon Noh
      Journal of Clinical Medicine.2019; 8(4): 494.     CrossRef
    • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
      Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
      Cancer Research and Treatment.2019; 51(2): 417.     CrossRef
    • Prediction of Cancer Incidence and Mortality in Korea, 2019
      Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
      Cancer Research and Treatment.2019; 51(2): 431.     CrossRef
    • Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors
      Ji Soo Park, Beodeul Kang, Yehyun Park, Soo Jung Park, Jae Hee Cheon, Minkyu Jung, Seung Hoon Beom, Sang Joon Shin, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Joong Bae Ahn, Nam Kyu Kim, Tae Il Kim
      Journal of Cancer Prevention.2019; 24(1): 48.     CrossRef
    • Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients
      Jung Youn Kim, Dae-Won Lee, Kyung-Hun Lee, Ahrum Min, Han Suk Ryu, Han-Byoel Lee, Hyeong-Gon Moon, Tae-Yong Kim, Sae-Won Han, Do-Youn Oh, Wonshik Han, In Ae Park, Dong-Young Noh, Seock-Ah Im, Sukil Kim
      Breast Cancer Research and Treatment.2019; 176(2): 453.     CrossRef
    • Sex and Gender Medicine in Pancreatobiliary Diseases
      Seon Mee Park
      The Korean Journal of Pancreas and Biliary Tract.2019; 24(2): 55.     CrossRef
    • Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma
      Ho Won Kang, Hongyong Park, Sung Pil Seo, Young Joon Byun, Xuan-Mei Piao, Sung Min Kim, Won Tae Kim, Seok-Joong Yun, Wooyeong Jang, Ho Sun Shon, Keun Ho Ryu, Sang-Cheol Lee, Wun-Jae Kim, Yong-June Kim
      Journal of Korean Medical Science.2019;[Epub]     CrossRef
    • Oncologic Outcomes in Patients Who Undergo Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision for Locally Advanced Rectal Cancer: A 14-Year Experience in a Single Institution
      Min Jung Kim, Seung-Yong Jeong, Ji Won Park, Seung-Bum Ryoo, Sang Sik Cho, Ki Young Lee, Kyu Joo Park
      Annals of Coloproctology.2019; 35(2): 83.     CrossRef
    • Small cell lung cancer starting with diabetes mellitus: Two case reports and literature review
      Tong Zhou, Yao Wang, Xue Zhao, Yang Liu, Ying-Xuan Wang, Xiao-Kun Gang, Gui-Xia Wang
      World Journal of Clinical Cases.2019; 7(10): 1213.     CrossRef
    • Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement
      Tae Ryong Chung, Jie-Hyun Kim, Ik Jae Lee, Yeona Cho, Jun Won Kim, Chang Geol Lee, Da Hyun Jung, Jae Jun Park, Young Hoon Youn, Hyojin Park
      Digestive and Liver Disease.2019; 51(11): 1610.     CrossRef
    • Incidence and Clinical Characteristics of Ischemic Stroke Patients with Underlying Cancer
      Soon Woo Kwon, Won Jun Meng, Hae in Lee, Doo Young Kim, Sung-Bom Pyun
      Brain & Neurorehabilitation.2019;[Epub]     CrossRef
    • Prevalence of human papillomavirus-related diseases in the Republic of Korea: a cross-sectional study
      Jin-Kyoung Oh, Hwa Young Choi, Minji Han, Jae-Kwan Lee, Kyung-Jin Min, Moran Ki
      Sexually Transmitted Infections.2019; 95(4): 292.     CrossRef
    • Pattern identification of lung cancer patients based on body constitution questionnaires (BCQ) and glycoproteomics for precision medicine
      Wonryeon Cho, Ji Hye Kim, Miseon Jeong, Myeong-Sun Kim, Jinwook Lee, Hyoungwoo Son, Chunhoo Cheon, Sunju Park, Seong-Gyu Ko
      Medicine.2019; 98(24): e16035.     CrossRef
    • Comparison of Postoperative Pain in Laparoscopy-Assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy by Location of Mini-Laparotomy Site
      Jaepak Yi, Yoona Chung, Sang Hyun Kim, Sung Il Choi
      The Journal of Minimally Invasive Surgery.2019; 22(2): 75.     CrossRef
    • Value of Computer Software for Assisting Sonographers in the Diagnosis of Thyroid Imaging Reporting and Data System Grade 3 and 4 Thyroid Space‐Occupying Lesions
      Yuanyuan Lu, Xian Quan Shi, Xiaohui Zhao, Danfei Song, Junlai Li
      Journal of Ultrasound in Medicine.2019; 38(12): 3291.     CrossRef
    • Mesothelin expression and its prognostic role according to microsatellite instability status in colorectal adenocarcinoma
      Hyunsung Kim, Yumin Chung, Seung Sam Paik, Kiseok Jang, Su-Jin Shin
      Medicine.2019; 98(26): e16207.     CrossRef
    • Cigarette smoking, alcohol consumption, and risk of colorectal cancer in South Korea: A case-control study
      Sanghee Lee, Hyeongtaek Woo, Jeeyoo Lee, Jae-Hwan Oh, Jeongseon Kim, Aesun Shin
      Alcohol.2019; 76: 15.     CrossRef
    • The economic burden of cancers attributable to smoking in Korea, 2014
      Thi Nguyen, Minji Han, Jin-Kyoung Oh
      Tobacco Induced Diseases.2019;[Epub]     CrossRef
    • Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia
      Sang Mee Hwang, Sung-Min Kim, Youngwon Nam, Jinhyun Kim, Sungsik Kim, Yong-Oon Ahn, Yong Park, Sung-Soo Yoon, Sue Shin, Sunghoon Kwon, Dong Soon Lee
      Leukemia Research.2019; 84: 106190.     CrossRef
    • The Health Burden of Cancer Attributable to Obesity in Korea: A Population-Based Cohort Study
      Joo Eun Lee, Chung Mo Nam, Sang Gyu Lee, Sohee Park, Tae Hyun Kim, Eun-Cheol Park
      Cancer Research and Treatment.2019; 51(3): 933.     CrossRef
    • Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients
      Jung Hye Kwon, Sang-Cheol Lee, Myung Ah Lee, Yu Jung Kim, Jung Hun Kang, Jin Young Kim, Hyo Jin Lee, Woo Kyun Bae, Mi-Jung Kim, Eui Kyu Chie, Jin Kim, Yeul Hong Kim, Hyun Cheol Chung, Sun Young Rha
      Cancer Research and Treatment.2019; 51(3): 851.     CrossRef
    • Menopausal Symptoms and Quality of Life Among Breast Cancer Patients with Chemotherapy-induced Amenorrhea
      Jin-Hee Park, Yong-Sik Jung, Ji Young Kim, Sun Hyoung Bae, Yujung Jo
      Asian Oncology Nursing.2019; 19(2): 90.     CrossRef
    • Higher Age Puts Lung Cancer Patients at Risk for Not Receiving Anti-cancer Treatment
      Won-Il Choi, Jiah Choi, Mi-Ae Kim, Gyumin Lee, Jihyeon Jeong, Choong Won Lee
      Cancer Research and Treatment.2019; 51(3): 1241.     CrossRef
    • Prevalence and risk factors of colorectal cancer in Asia
      Martin CS Wong, Hanyue Ding, Jingxuan Wang, Paul SF Chan, Junjie Huang
      Intestinal Research.2019; 17(3): 317.     CrossRef
    • Effects of Acupressure on Fatigue in Patients with Cancer Who Underwent Chemotherapy
      Atefeh Ghanbari Khanghah, Moloud Sharifi Rizi, Bahram Naderi Nabi, Masoumeh Adib, Ehsan Kazem Nejad Leili
      Journal of Acupuncture and Meridian Studies.2019; 12(4): 103.     CrossRef
    • Risk of malignancy in patients with psoriasis: a 15‐year nationwide population‐based prospective cohort study in Korea
      J.W. Lee, K.J. Jung, T.G. Kim, M. Lee, J. Oh, S.H. Jee, M.G. Lee
      Journal of the European Academy of Dermatology and Venereology.2019; 33(12): 2296.     CrossRef
    • Malignancy risk in Korean male patients with ankylosing spondylitis
      Bora Nam, Hyoungyoung Kim, Eun Jin Jang, Soo-Kyung Cho, Yoon-Kyoung Sung, Tae-Hwan Kim
      Rheumatology International.2019; 39(10): 1741.     CrossRef
    • Clinical Implementation of Precision Medicine in Gastric Cancer
      Jaewook Jeon, Jae-Ho Cheong
      Journal of Gastric Cancer.2019; 19(3): 235.     CrossRef
    • Platyphylloside Isolated from Betula platyphylla is Antiproliferative and Induces Apoptosis in Colon Cancer and Leukemic Cells
      Joo-Eun Lee, Nguyen Thi Thanh Thuy, Jina Lee, Namki Cho, Hee Min Yoo
      Molecules.2019; 24(16): 2960.     CrossRef
    • Risk of comorbid cardiovascular disease in Korean long‐term cancer survivors
      Jinyoung Shin, Hyeonyoung Ko, Yoon‐Ho Choi, Inyoung Choi, Yun‐Mi Song
      European Journal of Cancer Care.2019;[Epub]     CrossRef
    • Active and Passive Smoking, BRAFV600E Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study
      Kyoung-Nam Kim, Yunji Hwang, Kyungsik Kim, Kyu Eun Lee, Young Joo Park, June Young Choi, Do Joon Park, BeLong Cho, Daehee Kang, Sue K. Park
      Cancer Research and Treatment.2019; 51(4): 1392.     CrossRef
    • Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
      Jongmoo Park, Jae Won Park, Min Kyu Kang
      Yeungnam University Journal of Medicine.2019; 36(3): 192.     CrossRef
    • Anesthetics and long-term survival after cancer surgery—total intravenous versus volatile anesthesia: a retrospective study
      Boohwi Hong, Sunyeul Lee, Yeojung Kim, Minhee Lee, Ann Misun Youn, Hyun Rhim, Seok-Hwan Hong, Yoon-Hee Kim, Seok-Hwa Yoon, Chaeseong Lim
      BMC Anesthesiology.2019;[Epub]     CrossRef
    • Development and Effectiveness of an Oncology Nursing Standardized Patient Simulation Program for Nursing Students
      Kie In Jang, Yang Sook Yoo, Young Sook Roh
      Korean Journal of Adult Nursing.2019; 31(6): 595.     CrossRef
    • The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems
      Hyun-Soo Zhang, Eun-Kyung Lee, Yuh-Seog Jung, Byung-Ho Nam, Boyoung Park
      Cancer Epidemiology.2019; 63: 101589.     CrossRef
    • Genetic Analysis Can Surrogate the Treatment Strategies in Patients with Pancreatic Cancer
      Dong Uk Kim
      Gut and Liver.2019; 13(6): 587.     CrossRef
    • Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
      Sunghwan Suh, Kwang-Won Kim
      Diabetes & Metabolism Journal.2019; 43(6): 733.     CrossRef
    • Gastric Complications after Adjuvant Radiotherapy for Breast Cancer
      Won Kyung Cho, Doo Ho Choi, Won Park, Haeyoung Kim, Seonwoo Kim, Myung-Hee Shin, Hyejung Cha
      Journal of Breast Cancer.2019; 22(3): 464.     CrossRef
    • The Association between Cancer Screening and Cancer History among Korean Adults: The 2010–2012 Korea National Health and Nutrition Examination Survey
      Ye-Seul Kim, Hee-Taik Kang, Jae-Woo Lee
      Korean Journal of Family Medicine.2019; 40(5): 307.     CrossRef
    • Prevalence of Women with Dense Breasts in Korea: Results from a Nationwide Cross-sectional Study
      Hye-Mi Jo, Eun Hye Lee, Kyungran Ko, Bong Joo Kang, Joo Hee Cha, Ann Yi, Hae Kyoung Jung, Jae Kwan Jun
      Cancer Research and Treatment.2019; 51(4): 1295.     CrossRef
    • Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997–2016
      Jongmin Sim, Takuya Takayama, Junhun Cho, Seok Jin Kim, Won Seog Kim, Howe J. Ree, Young Hyeh Ko
      Medicine.2019; 98(45): e17641.     CrossRef
    • Milk Consumption Decreases Risk for Breast Cancer in Korean Women under 50 Years of Age: Results from the Health Examinees Study
      Woo-Kyoung Shin, Hwi-Won Lee, Aesun Shin, Jong-koo Lee, Daehee Kang
      Nutrients.2019; 12(1): 32.     CrossRef
    • Aerobic capacity correlates with health‐related quality of life after breast cancer surgery
      Doo Young Kim, Jae‐Hyung Kim, Si‐Woon Park
      European Journal of Cancer Care.2019;[Epub]     CrossRef
    • Korean First Prospective Phase II Study, Feasibility of Prone Position in Postoperative Whole Breast Radiotherapy: A Dosimetric Comparison
      Yoonsun Chung, Jeong Il Yu, Won Park, Doo Ho Choi
      Cancer Research and Treatment.2019; 51(4): 1370.     CrossRef
    • Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma
      Pyung Jung, Eung-Ho Cho, Sang-Bum Kim, Ryoung-Go Kim
      Annals of Hepato-Biliary-Pancreatic Surgery.2019; 23(4): 319.     CrossRef
    • Induced Tamoxifen Resistance is Mediated by Increased Methylation of E-Cadherin in Estrogen Receptor-Expressing Breast Cancer Cells
      Qi Wang, Melisa Gun, Xing-yu Hong
      Scientific Reports.2019;[Epub]     CrossRef
    • Evaluation of Commercial Complementary DNA Synthesis Kits for Detecting Human Papillomavirus
      Kwangmin Yu, Sunyoung Park, Yunhee Chang, Dasom Hwang, Geehyuk Kim, Jungho Kim, Sunghyun Kim, Eun-Joong Kim, Dongsup Lee
      The Korean Journal of Clinical Laboratory Science.2019; 51(3): 309.     CrossRef
    • The epidemiology of hepatitis B virus infection in Korea
      Sun Young Yim, Ji Hoon Kim
      The Korean Journal of Internal Medicine.2019; 34(5): 945.     CrossRef
    • Production and Performance Evaluation of External Quality Assessment Materials for Human Epididymis Protein 4 Assay
      Anna Lee, Hee-Jung Kim
      Journal of Laboratory Medicine and Quality Assurance.2019; 41(3): 153.     CrossRef
    • Clinical Implications of Microsatellite Instability in Early Gastric Cancer
      Dong Gyu Kim, Ji Yeong An, Hyunki Kim, Su-Jin Shin, Seohee Choi, Won Jun Seo, Chul Kyu Roh, Minah Cho, Taeil Son, Hyoung-Il Kim, Jae-Ho Cheong, Woo Jin Hyung, Sung Hoon Noh, Yoon Young Choi
      Journal of Gastric Cancer.2019; 19(4): 427.     CrossRef
    • Prognostic Value of Metabolic Information in Advanced Gastric Cancer Using Preoperative 18F-FDG PET/CT
      Hye Ryeong Kwon, Kisoo Pahk, Sungsoo Park, Hyun Woo Kwon, Sungeun Kim
      Nuclear Medicine and Molecular Imaging.2019; 53(6): 386.     CrossRef
    • Comparison of radiotherapy infrastructure between Korea and Japan
      Seung Jae Huh, Tetsuo Nishimura, Won Park, Katsumasa Nakamura
      Japanese Journal of Clinical Oncology.2019; 49(11): 1024.     CrossRef
    • Report of the Korean Association of Lung Cancer Registry (KALC-R), 2014
      Chang-Min Choi, Ho Cheol Kim, Chi Young Jung, Deog Gon Cho, Jae Hyun Jeon, Jeong Eun Lee, Jin Seok Ahn, Seung Joon Kim, Yeongdae Kim, Yoo-Duk Choi, Yang-Gun Suh, Jung-Eun Kim, Boram Lee, Young-Joo Won, Young-Chul Kim
      Cancer Research and Treatment.2019; 51(4): 1400.     CrossRef
    • Stage 1A Pancreatic Cancer Initially Manifesting as Clinical Acute Pancreatitis
      Dong Ryeol Yoo, Jihun Kim, Seung-Ho Baek, Jiwoo Lee, So Hye Nam, Se Hee Lee, Myung-Hwan Kim
      The Korean Journal of Medicine.2019; 94(6): 519.     CrossRef
    • A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer
      Yumi Kim, Un-Beom Kang, Sungsoo Kim, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh
      Journal of Breast Cancer.2019; 22(4): 579.     CrossRef
    • Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to Evaluate Effectiveness and Feasibility to Implement National Cancer Screening Program
      Jaeho Lee, Juntae Lim, Yeol Kim, Hyae Young Kim, Jin Mo Goo, Choon-Taek Lee, Seung Hun Jang, Won-Chul Lee, Chan Wha Lee, Jin Young An, Ki Dong Ko, Min Ki Lee, Kui Son Choi, Boyoung Park, Duk Hyoung Lee
      Cancer Research and Treatment.2019; 51(4): 1285.     CrossRef
    • Relief of Cancer Pain in Patients with Pancreatic Cancer
      Jung Wan Choe, Jong Jin Hyun
      The Korean Journal of Gastroenterology.2019; 74(2): 81.     CrossRef
    • Recent Trends in Demographics, Surgery, and Prognosis of Patients with Surgically Resected Lung Cancer in a Single Institution from Korea
      Jae Kwang Yun, Han Pil Lee, Geun Dong Lee, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Sehoon Choi
      Journal of Korean Medical Science.2019;[Epub]     CrossRef
    • Colorectal Cancer Risks According to Sex Differences in Patients With Type II Diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study
      Ji Min Lee, Kang-Moon Lee, Dae Bum Kim, Seung-Hyun Ko, Yong Gyu Park
      Clinical and Translational Gastroenterology.2019; 10(10): e00090.     CrossRef
    • Increased Risk of Osteoporotic Fracture in Postgastrectomy Gastric Cancer Survivors Compared With Matched Controls: A Nationwide Cohort Study in Korea
      Dong Wook Shin, Beomseok Suh, Hyunsun Lim, Yun-Suhk Suh, Yoon Jin Choi, Su-Min Jeong, Jae Moon Yun, Sun Ok Song, Youngmin Park
      American Journal of Gastroenterology.2019; 114(11): 1735.     CrossRef
    • Clinical significance of the De Ritis ratio for detecting prostate cancer in a repeat prostate biopsy
      Heon Ha, Jae-Wook Chung, Yun-Sok Ha, Seock Hwan Choi, Jun Nyung Lee, Bum Soo Kim, Hyun Tae Kim, Tae-Hwan Kim, Ghil Suk Yoon, Tae Gyun Kwon, Sung Kwang Chung, Eun Sang Yoo
      Investigative and Clinical Urology.2019; 60(6): 447.     CrossRef
    • Protective Effect of Green Tea Consumption on Colorectal Cancer Varies by Lifestyle Factors
      Hyejin Kim, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
      Nutrients.2019; 11(11): 2612.     CrossRef
    • Neutrophil‐to‐lymphocyte ratio and risk of lung cancer mortality in a low‐risk population: A cohort study
      Jihoon Kang, Yoosoo Chang, Jiin Ahn, Sukjoong Oh, Dong‐Hoe Koo, Yun‐Gyoo Lee, Hocheol Shin, Seungho Ryu
      International Journal of Cancer.2019; 145(12): 3267.     CrossRef
    • Association between the relative abundance of gastric microbiota and the risk of gastric cancer: a case-control study
      Madhawa Neranjan Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Yongju Ahn, Chanhyeok Park, Jeongseon Kim
      Scientific Reports.2019;[Epub]     CrossRef
    • Epidemiology of and Risk Factors for Esophageal Cancer in Korea
      Hye-Kyung Jung
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2019; 19(3): 145.     CrossRef
    • Validation of an automated adenoma detection rate calculating system for quality improvement of colonoscopy
      Dae Kyung Sohn, Il Won Shin, Jeonghwa Yeon, Jin Yoo, Byung Chang Kim, Bun Kim, Chang Won Hong, Kyung Su Han
      Annals of Surgical Treatment and Research.2019; 97(6): 319.     CrossRef
    • Sex-specific differences in risk factors of lymph node metastasis in patients with early gastric cancer
      Eun Sook Ryu, Seung Jun Chang, Jungsuk An, Jun-Young Yang, Jun-Won Chung, Yoon Jae Kim, Kyoung Oh Kim, Dong Kyun Park, Kwang An Kwon, Seungyoon Nam, Woon Kee Lee, Jung Ho Kim, Masaru Katoh
      PLOS ONE.2019; 14(10): e0224019.     CrossRef
    • Knowledge and Anxiety Related to Hereditary Ovarian Cancer in Serous Ovarian Cancer Patients
      Sang Hee Lee, Hyangkyu Lee, Myong Cheol Lim, Sue Kim
      Korean Journal of Women Health Nursing.2019; 25(4): 365.     CrossRef
    • Alcohol consumption and gastric cancer risk in Korea: a case-control study
      Mi Hui Kim, Shin Ah Kim, Chan Hyuk Park, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Kyu Sang Song, Bo Youl Choi, Hyun Ja Kim
      Nutrition Research and Practice.2019; 13(5): 425.     CrossRef
    • Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer
      Yujun Park, Jiwon Koh, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
      Cancer Immunology, Immunotherapy.2019; 68(11): 1779.     CrossRef
    • Determinants of undergoing thyroid cancer screening in Korean women: a cross-sectional analysis from the K-Stori 2016
      Ha Na Cho, Eunji Choi, Da Hea Seo, Boyoung Park, Sohee Park, Juhee Cho, Sue Kim, Yeong-Ran Park, Yumie Rhee, Kui Son Choi
      BMJ Open.2019; 9(4): e026366.     CrossRef
    • Different Patterns of Conditional Survival of Breast Cancer Patients by Age and Histologic Types: Evidence from the Korean Nationwide Registry
      So-Youn Jung, Kyu-Won Jung, Johyun Ha, Young-Joo Won, Young Ae Kim, Youngmee Kwon, Sun-Young Kong, Eun Sook Lee
      Cancer Epidemiology, Biomarkers & Prevention.2019; 28(7): 1169.     CrossRef
    • Cancer Incidence Trend in the Hebei Spirit Oil Spill Area, from 1999 to 2014: An Ecological Study
      Kyung-Hwa Choi, Myung-Sook Park, Mina Ha, Jong-Il Hur, Hae-Kwan Cheong
      International Journal of Environmental Research and Public Health.2018; 15(5): 1006.     CrossRef
    • Updates on Cancer Epidemiology in Korea, 2018
      Sun-Seog Kweon
      Chonnam Medical Journal.2018; 54(2): 90.     CrossRef
    • Avoiding “curiosity killed the cat”: personalized surveillance in post-resection colorectal cancer patients
      Hyunkyung Park, Joohan Lim
      The Korean Journal of Internal Medicine.2018; 33(4): 693.     CrossRef
    • Incidence and risk factors of subsyndromal delirium after curative resection of gastric cancer
      Heesung Hwang, Kwang-Min Lee, Kyung-Lak Son, Dooyoung Jung, Won-Hyoung Kim, Joo-Young Lee, Seong-Ho Kong, Yun-Suhk Suh, Hyuk-Joon Lee, Han-Kwang Yang, Bong-Jin Hahm
      BMC Cancer.2018;[Epub]     CrossRef
    • Dietary Carotenoids Intake and the Risk of Gastric Cancer: A Case—Control Study in Korea
      Ji Hyun Kim, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Oran Kwon, Hyesook Kim, Jeongseon Kim
      Nutrients.2018; 10(8): 1031.     CrossRef
    • Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review
      Hyeong Su Kim, Jung Han Kim, Hyun Joo Jang, Boram Han, Dae Young Zang
      International Journal of Molecular Sciences.2018; 19(9): 2529.     CrossRef
    • Immune checkpoint inhibitors for urothelial carcinoma
      Hyung Suk Kim, Ho Kyung Seo
      Investigative and Clinical Urology.2018; 59(5): 285.     CrossRef
    • Characteristics and Survival of Korean Patients With Colorectal Cancer Based on Data From the Korea Central Cancer Registry Data
      Hyuk Hur, Chang-Mo Oh, Young-Joo Won, Jae Hwan Oh, Nam Kyu Kim
      Annals of Coloproctology.2018; 34(4): 212.     CrossRef
    • Patterns of Practice in Radiotherapy for Breast Cancer in Korea
      Hae Jin Park, Do Hoon Oh, Kyung Hwan Shin, Jin Ho Kim, Doo Ho Choi, Won Park, Chang-Ok Suh, Yong Bae Kim, Seung Do Ahn, Su Ssan Kim
      Journal of Breast Cancer.2018; 21(3): 244.     CrossRef
    • Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG)
      Miseon Kim, Young-Han Kim, Yong Beom Kim, Jayeon Kim, Jae-Weon Kim, Mi Hye Park, Joo Hyun Park, Jeong Ho Rhee, Myong Cheol Lim, Joon-Seok Hong
      Obstetrics & Gynecology Science.2018; 61(5): 542.     CrossRef
    • Cause-of-death statistics in 2016 in the Republic of Korea
      Hyun-Young Shin, Ji-Youn Lee, Jee-Eun Kim, Seokmin Lee, Heejo Youn, Heyran Kim, Jeonghun Lee, Min Sim Park, Sun Huh
      Journal of the Korean Medical Association.2018; 61(9): 573.     CrossRef
    • Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data
      Il Yong Chung, Jihyoun Lee, Suyeon Park, Jong Won Lee, Hyun Jo Youn, Jung Hwa Hong, Ho Hur
      Journal of Korean Medical Science.2018;[Epub]     CrossRef
    • Physical Activity and Gastric Cancer Risk in Patients with and without Helicobacter pylori Infection in A Korean Population: A Hospital-Based Case-Control Study
      Madhawa Neranjan Gunathilake, Jeonghee Lee, Aelee Jang, Il Ju Choi, Young-Il Kim, Jeongseon Kim
      Cancers.2018; 10(10): 369.     CrossRef
    • Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females
      Jeong-Hwa Choi, Jeonghee Lee, Sarah Yang, Eun Kyung Lee, Yul Hwangbo, Jeongseon Kim
      Scientific Reports.2018;[Epub]     CrossRef
    • Waiting and Hope: Optimal Time Interval for Surgery After Long-Course Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
      Chang Hyun Kim
      Annals of Coloproctology.2018; 34(5): 227.     CrossRef
    • Evaluation of the Association between Gestational Diabetes Mellitus at First Pregnancy and Cancer within 10 Years Postpartum Using National Health Insurance Data in South Korea
      Kyu-Tae Han, Geum Joon Cho, Eui Hyeok Kim
      International Journal of Environmental Research and Public Health.2018; 15(12): 2646.     CrossRef
    • Helicobacter pylori Eradication Therapy and Gastric Cancer Prevention
      Il Ju Choi
      The Korean Journal of Gastroenterology.2018; 72(5): 245.     CrossRef
    • Projected lifetime cancer risks from occupational radiation exposure among diagnostic medical radiation workers in South Korea
      Won Jin Lee, Yeongchull Choi, Seulki Ko, Eun Shil Cha, Jaeyoung Kim, Young Min Kim, Kyoung Ae Kong, Songwon Seo, Ye Jin Bang, Yae Won Ha
      BMC Cancer.2018;[Epub]     CrossRef
    • The Risk of Colorectal Cancer After Cholecystectomy or Appendectomy: A Population-based Cohort Study in Korea
      Joonki Lee, Sunho Choe, Ji Won Park, Seung-Yong Jeong, Aesun Shin
      Journal of Preventive Medicine and Public Health.2018; 51(6): 281.     CrossRef
    • Change in the Prevalences and Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in Korea: Multicenter Clinical Trials
      Young-Jae Hwang, Nayoung Kim, Sung Eun Kim, Gwang Ho Baik, Ju Yup Lee, Kyung Sik Park, Young-Eun Joo, Dae-Seong Myung, Hyeon Ju Kim, Hyun Joo Song, Heung Up Kim, Kwangwoo Nam, Jeong Eun Shin, Hyun Jin Kim, Gwang Ha Kim, Jongchan Lee, Seon Hee Lim, Geom Se
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2018; 18(4): 247.     CrossRef
    • MHY440, a Novel Topoisomerase Ι Inhibitor, Induces Cell Cycle Arrest and Apoptosis via a ROS-Dependent DNA Damage Signaling Pathway in AGS Human Gastric Cancer Cells
      Jung Yoon Jang, Yong Jung Kang, Bokyung Sung, Min Jeong Kim, Chaeun Park, Dongwan Kang, Hyung Ryong Moon, Hae Young Chung, Nam Deuk Kim
      Molecules.2018; 24(1): 96.     CrossRef
    • Factors Affecting Cognitive Function in Patients with Stomach Cancer
      Yeoung Ji Yu, Seung Hee Ahn, Yong Ae Cho, Eunjung Ryu, Eun-Ju Kim
      Asian Oncology Nursing.2018; 18(4): 241.     CrossRef
    • Mouse models of breast cancer in preclinical research
      Mi Kyung Park, Chang Hoon Lee, Ho Lee
      Laboratory Animal Research.2018; 34(4): 160.     CrossRef
    • Treatment of Patients with Cancer in a Secondary Hospital in Korea
      Myoung Kyun Son
      The Korean Journal of Hospice and Palliative Care.2018; 21(3): 84.     CrossRef
    • Influence of Insurance Status on Survival of Surgically Treated Esophageal Cancer Patients
      Yoohwa Hwang, Se-Jin Oh, Jae-Sung Choi, Ji Won Kim, Jeong Sang Lee, Hyun Jong Moon
      The Korean Journal of Gastroenterology.2018; 72(1): 15.     CrossRef
    • Potential Epigenetic Biomarkers for Prostate Cancer Screening
      Jong-Myon Bae
      International Neurourology Journal.2018; 22(2): 142.     CrossRef
    • Induction of apoptosis and G1 phase cell cycle arrest by Aster�incises in AGS gastric adenocarcinoma cells
      Daniel Ngabire, Yeong-Ae Seong, Maheshkumar Prakash Patil, Irvine Niyonizigiye, Yong Bae Seo, Gun-Do Kim
      International Journal of Oncology.2018;[Epub]     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
      Cancer Res Treat. 2018;50(2):303-316.   Published online March 21, 2018
      Close
    • XML DownloadXML Download
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
    Image Image Image Image Image Image
    Fig. 1. Annual age-standardized cancer incidence and death rates by sex for all sites from 1983 to 2015 in Korea. Age standardization was based on the Segi’s world standard population.
    Fig. 2. Trends in age-standardized incidences of selected cancers by sex from 1999 to 2015 in Korea. Age standardization was based on the Segi’s world standard population. (A) Men. (B) Women.
    Fig. 3. Annual age-standardized cancer mortalities of selected cancers by sex from 1983 to 2015 in Korea. (A) Men. (B) Women. Age-standardization was based on the Segi’s world standard population.
    Fig. 4. Age-specific incidence rates of common cancers for 2015 in Korea. (A) Men. (B) Women.
    Fig. 5. Trends in relative survival by year of diagnosis from 1999 to 2014. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.
    Fig. 6. Prevalence of common cancer sites by time period after cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2016 among all cancer patients diagnosed between 1999 and 2015.
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
    Site/Type New cases
    Deaths
    Prevalent casesa)
    Both sexes Men Women Both sexes Men Women Both sexes Men Women
    All sites 214,701 113,335 101,366 76,855 47,678 29,177 1,611,487 707,977 903,510
    Lip, oral cavity, and pharynx 3,309 2,390 919 1,170 884 286 21,827 14,656 7,171
    Esophagus 2,420 2,201 219 1,531 1,401 130 9,171 8,262 909
    Stomach 29,207 19,545 9,662 8,526 5,507 3,019 256,995 170,294 86,701
    Colon and rectum 26,790 15,911 10,879 8,301 4,698 3,603 220,653 131,579 89,074
    Liver 15,757 11,732 4,025 11,311 8,382 2,929 61,290 45,881 15,409
    Gallbladderb) 6,251 3,220 3,031 4,211 2,135 2,076 19,468 9,958 9,510
    Pancreas 6,342 3,359 2,983 5,439 2,908 2,531 9,517 5,031 4,486
    Larynx 1,146 1,079 67 344 319 25 10,049 9,452 597
    Lung 24,267 17,015 7,252 17,399 12,677 4,722 69,931 43,987 25,944
    Breast 19,219 77 19,142 2,354 16 2,338 179,081 686 178,395
    Cervix uteri 3,582 - 3,582 967 - 3,582 50,477 - 3,582
    Corpus uteri 2,404 - 2,404 319 - 2,404 20,859 - 2,404
    Ovary 2,443 - 2,443 1,055 - 2,443 18,112 - 2,443
    Prostate 10,212 10,212 - 1,700 1,700 - 69,438 69,438 -
    Testis 286 286 - 10 10 - 2,939 2,939 -
    Kidney 4,555 3,134 1,421 952 672 280 35,333 23,862 11,471
    Bladder 4,033 3,245 788 1,299 960 339 31,407 25,609 5,798
    Brain and CNS 1,776 958 818 1,266 674 592 10,349 5,334 5,015
    Thyroid 25,029 5,386 19,643 341 106 235 355,057 60,151 294,906
    Hodgkin lymphoma 271 174 97 49 33 16 2,571 1,623 948
    Non-Hodgkin lymphoma 4,396 2,519 1,877 1,771 1,026 745 27,478 15,622 11,856
    Multiple myeloma 1,455 762 693 889 466 423 5,330 2,779 2,551
    Leukemia 3,242 1,830 1,412 1,720 1,003 717 19,260 10,654 8,606
    Other and ill defined 16,309 8,300 8,009 3,931 2,101 1,830 104,895 50,180 54,715
    Site/Type Crude incidence rate per 100,000
    Age-standardized incidence rate per 100,000a)
    Both sexes Men Women Both sexes Men Women
    All sites 421.4 445.2 397.6 258.9 291.7 241.1
    Lip, oral cavity, and pharynx 6.5 9.4 3.6 4.1 6.2 2.2
    Esophagus 4.7 8.6 0.9 2.7 5.5 0.4
    Stomach 57.3 76.8 37.9 33.8 49.3 20.5
    Colon and rectum 52.6 62.5 42.7 30.4 40.2 22.2
    Liver 30.9 46.1 15.8 18.2 29.5 8.2
    Gallbladderb) 12.3 12.6 11.9 6.6 8.0 5.5
    Pancreas 12.4 13.2 11.7 7.0 8.5 5.7
    Larynx 2.2 4.2 0.3 1.3 2.7 0.1
    Lung 47.6 66.8 28.4 26.4 42.3 14.3
    Breast 37.7 0.3 75.1 24.8 0.2 49.2
    Cervix uteri 7.0 - 14.1 4.6 - 9.1
    Corpus uteri 4.7 - 9.4 3.1 - 6.1
    Ovary 4.8 - 9.6 3.2 - 6.3
    Prostate 20.0 40.1 - 11.2 25.4 -
    Testis 0.6 1.1 - 0.6 1.1 -
    Kidney 8.9 12.3 5.6 5.7 8.2 3.4
    Bladder 7.9 12.7 3.1 4.3 8.1 1.5
    Brain and CNS 3.5 3.8 3.2 2.8 3.1 2.4
    Thyroid 49.1 21.2 77.1 35.2 15.1 55.6
    Hodgkin lymphoma 0.5 0.7 0.4 0.5 0.6 0.4
    Non-Hodgkin lymphoma 8.6 9.9 7.4 5.9 7.2 4.6
    Multiple myeloma 2.9 3.0 2.7 1.6 1.9 1.4
    Leukemia 6.4 7.2 5.5 5.3 6.2 4.5
    Other and ill defined 32.0 32.6 31.4 19.7 22.6 17.4
    Rank Cause of death No. of deaths (%) Age-standardized death rate per 100,000a)
    All causes 275,895 (100) 289.3
    1 Cancer 76,855 (27.9) 82.0
    2 Heart disease 28,326 (10.3) 27.9
    3 Cerebrovascular disease 24,455 (8.9) 23.4
    4 Pneumonia 14,718 (5.3) 13.5
    5 Intentional self-harm (suicide) 13,513 (4.9) 18.3
    6 Diabetes mellitus 10,558 (3.8) 10.2
    7 Chronic lower respiratory diseases 7,538 (2.7) 6.8
    8 Disease of liver 6,847 (2.5) 8.1
    9 Transport accidents 5,539 (2.0) 7.6
    10 Hypertensive diseases 5,050 (1.8) 4.6
    Others 82,496 (29.9) 87.1
    Site/Type Crude mortality rate per 100,000
    Age-standardized mortality rate per 100,000a)
    Both sexes Men Women Both sexes Men Women
    All sites 150.8 187.3 114.4 82.0 119.6 54.6
    Lip, oral cavity, and pharynx 2.3 3.5 1.1 1.3 2.3 0.6
    Esophagus 3.0 5.5 0.5 1.6 3.4 0.2
    Stomach 16.7 21.6 11.8 8.9 13.8 5.4
    Colon and rectum 16.3 18.5 14.1 8.5 11.8 6.1
    Liver 22.2 32.9 11.5 12.6 20.9 5.4
    Gallbladderb) 8.3 8.4 8.1 4.2 5.3 3.4
    Pancreas 10.7 11.4 9.9 5.7 7.2 4.5
    Larynx 0.7 1.3 0.1 0.4 0.8 0.0
    Lung 34.1 49.8 18.5 17.9 31.2 8.2
    Breast 4.6 0.1 9.2 2.8 0.0 5.5
    Cervix uteri 1.9 - 3.8 1.1 - 2.0
    Corpus uteri 0.6 - 1.3 0.4 - 0.7
    Ovary 2.1 - 4.1 1.2 - 2.2
    Prostate 3.3 6.7 - 1.6 4.3 -
    Testis 0.0 0.0 - 0.0 0.0 -
    Kidney 1.9 2.6 1.1 1.0 1.7 0.5
    Bladder 2.5 3.8 1.3 1.2 2.4 0.5
    Brain and CNS 2.5 2.6 2.3 1.7 1.9 1.5
    Thyroid 0.7 0.4 0.9 0.3 0.3 0.4
    Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
    Non-Hodgkin lymphoma 3.5 4.0 2.9 2.0 2.7 1.4
    Multiple myeloma 1.7 1.8 1.7 1.0 1.2 0.8
    Leukemia 3.4 3.9 2.8 2.2 2.8 1.7
    Other and ill defined 7.7 8.3 7.2 4.3 5.5 3.5
    Site/Type Both sexes
    Men
    Women
    1999 2015 Trend 1
    Trend 2
    1999 2015 Trend 1
    Trend 2
    1999 2015 Trend 1
    Trend 2
    Year APC Year APC Year APC Year APC Year APC Year APC
    All sites 210.5 258.9 1999-2012 3.4a) 2012-2015 –6.1a) 285.0 291.7 1999-2011 1.7a) 2011-2015 –3.6a) 161.1 241.1 1999-2012 5.5a) 2012-2015 –7.5a)
    Lip, oral cavity, and pharynx 3.6 4.1 1999-2015 0.5a) - - 6.1 6.2 1999-2015 –0.2 - - 1.6 2.2 1999-2015 1.4a) - -
    Esophagus 4.1 2.7 1999-2015 –2.3a) - - 8.8 5.5 1999-2015 –2.7a) - - 0.6 0.4 1999-2015 –1.8a) - -
    Stomach 43.6 33.8 1999-2011 –0.1 2011-2015 –5.7a) 66.2 49.3 1999-2011 –0.3 2011-2015 –6.2a) 26.7 20.5 1999-2011 –0.3 2011-2015 –5.1a)
    Colon and rectum 20.4 30.4 1999-2010 6.0a) 2010-2015 –4.9a) 26.2 40.2 1999-2010 6.5a) 2010-2015 –5.4a) 16.4 22.2 1999-2010 4.9a) 2010-2015 –4.3a)
    Liver 27.9 18.2 1999-2010 –1.7a) 2010-2015 –4.6a) 46.8 29.5 1999-2009 –1.9a) 2009-2015 –4.2a) 12.3 8.2 1999-2010 –1.5a) 2010-2015 –5.0a)
    Gallbladderb) 6.5 6.6 1999-2004 1.5 2004-2015 –0.3 8.1 8.0 1999-2015 0.0 - - 5.4 5.5 1999-2003 2.5 2003-2015 –0.6a)
    Pancreas 5.6 7.0 1999-2015 1.4a) - - 7.8 8.5 1999-2015 0.7a) - - 4.0 5.7 1999-2015 2.2a) - -
    Larynx 2.3 1.3 1999-2015 –3.6a) - - 4.9 2.7 1999-2015 –3.8a) - - 0.4 0.1 1999-2007 –8.9a) 2007-2015 –4.2a)
    Lung 28.5 26.4 1999-2011 0.1 2011-2015 –1.8a) 51.4 42.3 1999-2005 –0.1 2005-2015 –1.6a) 12.4 14.3 1999-2012 1.9a) 2012-2015 –2.0
    Breast 10.7 24.8 1999-2007 6.9a) 2007-2015 4.0a) 0.2 0.2 1999-2015 –1.1 - - 20.9 49.2 1999-2007 7.1a) 2007-2015 4.1a)
    Cervix uteri 8.5 4.6 1999-2015 –3.9a) - - - - - - - - 16.3 9.1 1999-2015 –3.7a) - -
    Corpus uteri 1.4 3.1 1999-2009 6.2a) 2009-2015 3.1a) - - - - - - 2.8 6.1 1999-2009 6.4a) 2009-2015 3.3a)
    Ovary 2.7 3.2 1999-2015 1.6a) - - - - - - - - 5.0 6.3 1999-2015 1.8a) - -
    Prostate 3.1 11.2 1999-2009 15.3a) 2009-2015 0.3 8.4 25.4 1999-2009 13.7a) 2009-2015 –0.5 - - - - - -
    Testis 0.3 0.6 1999-2015 4.9a) - - 0.6 1.1 1999-2015 4.8a) - - - - - - - -
    Kidney 3.0 5.7 1999-2009 6.7a) 2009-2015 1.3a) 4.5 8.2 1999-2010 6.1a) 2010-2015 0.4 1.7 3.4 1999-2009 6.6a) 2009-2015 1.1
    Bladder 4.6 4.3 1999-2004 2.4a) 2004-2015 –1.5a) 9.0 8.1 1999-2005 1.5a) 2005-2015 –1.8a) 1.6 1.5 1999-2003 2.6 2003-2015 –1.7a)
    Brain and CNS 2.9 2.8 1999-2008 1.3a) 2008-2015 –1.6a) 3.2 3.1 1999-2009 1.2a) 2009-2015 –2.0 2.6 2.4 1999-2007 1.5 2007-2015 –1.5a)
    Thyroid 6.3 35.2 1999-2011 22.8a) 2011-2015 –13.3a) 2.1 15.1 1999-2012 22.9a) 2012-2015 –16.9a) 10.4 55.6 1999-2011 22.4a) 2011-2015 –14.4a)
    Hodgkin lymphoma 0.2 0.5 1999-2015 4.1a) - - 0.4 0.6 1999-2015 3.2a) - - 0.1 0.4 1999-2015 5.3a) - -
    Non-Hodgkin lymphoma 4.3 5.9 1999-2015 2.3a) - - 5.6 7.2 1999-2015 1.9a) - - 3.3 4.6 1999-2015 2.6a) - -
    Multiple myeloma 1.0 1.6 1999-2015 3.3a) - - 1.2 1.9 1999-2015 3.0a) - - 0.8 1.4 1999-2015 3.5a) - -
    Leukemia 4.7 5.3 1999-2015 0.9a) - - 5.5 6.2 1999-2015 1.0a) - - 3.9 4.5 1999-2015 0.7a) - -
    Other and ill defined 14.4 19.7 1999-2008 3.5a) 2008-2015 1.3a) 18.1 22.6 1999-2015 1.8a) - - 11.9 17.4 1999-2011 3.8a) 2011-2015 –0.3
    Site/Type Both sexes
    Men
    Women
    1999 2015 Trend 1
    Trend 2
    1999 2015 Trend 1
    Trend 2
    1999 2015 Trend 1
    Trend 2
    Year APC Year APC Year APC Year APC Year APC Year APC
    All sites 114.3 82.0 1999-2002 1.0 2002-2015 –2.7a) 176.6 119.6 1999-2002 1.2 2002-2015 –3.1a) 70.6 54.6 1999-2002 1.0 2002-2015 –2.2a)
    Lip, oral cavity, and pharynx 1.1 1.3 1999-2015 –1.8a) - - 2.0 2.3 1999-2015 –2.1a) - - 0.4 0.6 1999-2015 –2.7a) - -
    Esophagus 3.1 1.6 1999-2015 –4.4a) - - 6.8 3.4 1999-2015 –4.6a) - - 0.5 0.2 1999-2015 –5.1a) - -
    Stomach 23.8 8.9 1999-2003 –3.3a) 2003-2015 –6.7a) 36.9 13.8 1999-2003 –2.6a) 2003-2015 –7.0a) 14.6 5.4 1999-2003 –4.4a) 2003-2015 –6.6a)
    Colon and rectum 7.7 8.5 1999-2004 5.5a) 2004-2015 –1.3a) 10.5 11.8 1999-2004 5.9a) 2004-2015 –1.0a) 6.0 6.1 1999-2004 4.9a) 2004-2015 –1.8a)
    Liver 20.4 12.6 1999-2002 0.8 2002-2015 –3.6a) 35.3 20.9 1999-2002 –0.1 2002-2015 –3.7a) 8.3 5.4 1999-2002 2.9 2002-2015 –3.7a)
    Gallbladderb) 5.2 4.2 1999-2001 7.4 2001-2015 –2.7a) 6.8 5.3 1999-2001 6.2 2001-2015 –2.8a) 4.1 3.4 1999-2001 9.2 2001-2015 –2.6a)
    Pancreas 5.4 5.7 1999-2015 0.3a) - - 7.6 7.2 1999-2015 –0.4a) - - 3.9 4.5 1999-2015 0.9a) - -
    Larynx 1.6 0.4 1999-2015 –9.5a) - - 3.4 0.8 1999-2015 –9.1a) - - 0.4 0.0 1999-2010 –15.4a) 2010-2015 –6.2
    Lung 22.4 17.9 1999-2002 1.8 2002-2015 –2.1a) 41.5 31.2 1999-2001 4.3 2001-2015 –2.5a) 9.4 8.2 1999-2002 2.3 2002-2015 –1.5a)
    Breast 2.2 2.8 1999-2015 1.4a) - - 0.1 0.0 1999-2015 –4.5a) - - 4.2 5.5 1999-2015 1.7a) - -
    Cervix uteri 1.4 1.1 1999-2003 8.4a) 2003-2015 –5.2a) - - - - - - 2.6 2.0 1999-2003 7.8a) 2003-2015 –4.9a)
    Corpus uteri 0.1 0.4 1999-2002 51.8a) 2002-2015 3.4a) - - - - - - 0.1 0.7 1999-2002 51.6a) 2002-2015 3.8a)
    Ovary 0.9 1.2 1999-2001 10.9 2001-2015 0.2 - - - - - - 1.7 2.2 1999-2001 10.2 2001-2015 0.5
    Prostate 0.9 1.6 1999-2004 9.4a) 2004-2015 0.4 2.6 4.3 1999-2002 17.5a) 2002-2015 0.3 - - - - - -
    Testis 0.0 0.0 1999-2015 –2.5 - - 0.1 0.0 1999-2015 2.9 - - - - - - - -
    Kidney 1.1 1.0 1999-2015 –0.1 - - 1.8 1.7 1999-2015 0.0 - - 0.5 0.5 1999-2015 –0.8 - -
    Bladder 1.3 1.2 1999-2015 –1.3a) - - 2.6 2.4 1999-2015 –1.6a) - - 0.5 0.5 1999-2001 10.8 2001-2015 –1.9a)
    Brain and CNS 1.9 1.7 1999-2002 4.4 2002-2015 –2.0a) 2.2 1.9 1999-2015 –1.5a) - - 1.6 1.5 1999-2015 –1.4a) - -
    Thyroid 0.4 0.3 1999-2003 7.0 2003-2015 –4.2a) 0.3 0.3 1999-2002 16.0 2002-2015 –4.0a) 0.5 0.4 1999-2004 4.3 2004-2015 –4.7a)
    Hodgkin lymphoma 0.0 0.1 1999-2003 29.6 2003-2015 –0.2 0.0 0.1 1999-2004 19.2a) 2004-2015 –2.0 0.0 0.0 1999-2003 40.8 2003-2015 1.3
    Non-Hodgkin lymphoma 2.1 2.0 1999-2015 –0.5a) - - 3.0 2.7 1999-2015 –0.8a) - - 1.4 1.4 1999-2015 –0.2 - -
    Multiple myeloma 0.6 1.0 1999-2003 12.8a) 2003-2015 0.8 0.8 1.2 1999-2003 10.9a) 2003-2015 0.8 0.4 0.8 1999-2007 7.4a) 2007-2015 –1.1
    Leukemia 2.9 2.2 1999-2001 1.4 2001-2015 –2.1a) 3.5 2.8 1999-2015 –1.7a) - - 2.4 1.7 1999-2015 –2.1a) - -
    Other and ill defined 7.8 4.3 1999-2015 –3.1a) - - 9.0 5.5 1999-2009 –0.6 2009-2015 –6.8a) 7.0 3.5 1999-2005 –7.0a) 2005-2015 –2.2a)
    Rank Age (yr)
    0-14 15-34 35-64 ≥ 65
    Men
     1 Leukemia (4.7) Thyroid (11.9) Stomach (81.9) Lung (436.0)
     2 Non-Hodgkin lymphoma (2.7) Leukemia (3.8) Colon and rectum (62.9) Stomach (353.5)
     3 Brain and CNS (1.9) Non-Hodgkin lymphoma (2.8) Liver (56.9) Colon and rectum (300.4)
     4 Kidney (0.5) Colon and rectum (2.7) Lung (42.1) Prostate (284.2)
     5 Liver (0.4) Testis (2.3) Thyroid (33.7) Liver (178.7)
    Women
     1 Leukemia (4.1) Thyroid (45.9) Breast (132.5) Colon and rectum (168.4)
     2 Brain and CNS (1.6) Breast (10.9) Thyroid (125.6) Stomach (137.0)
     3 Non-Hodgkin lymphoma (1.5) Cervix uteri (5.2) Colon and rectum (37.0) Lung (122.1)
     4 Thyroid (0.9) Ovary (3.0) Stomach (36.5) Breast (78.2)
     5 Ovary (0.6) Stomach (2.9) Lung (21.9) Live (66.3)
    Site/Type Both sexes
    Men
    Women
    1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 Changea)
    All sites 41.2 44.0 54.0 65.2 70.7 29.5 31.7 35.3 45.4 56.5 62.8 31.1 53.4 55.3 64.2 74.2 78.4 25.0
    Lip, oral cavity, and pharynx 41.1 46.7 54.3 60.6 64.5 23.4 35.8 41.1 49.4 56.4 60.7 24.9 58.1 63.8 67.8 71.7 74.1 16.0
    Esophagus 12.7 15.2 21.4 29.6 36.0 23.3 11.8 14.3 20.6 29.0 35.7 23.9 23.7 24.2 29.7 36.5 39.3 15.6
    Stomach 42.8 46.6 57.8 68.1 75.4 32.6 43.0 46.9 58.4 68.7 76.3 33.3 42.6 46.0 56.5 66.7 73.7 31.1
    Colon and rectum 54.8 58.0 66.7 73.5 76.3 21.5 55.3 59.0 68.5 75.4 78.0 22.7 54.2 56.8 64.3 70.8 73.6 19.4
    Liver 10.7 13.2 20.4 28.1 33.6 22.9 9.9 12.9 20.3 28.1 34.1 24.2 13.6 14.2 20.9 28.1 32.2 18.6
    Gallbladderb) 17.3 19.7 23.1 26.8 29.1 11.8 16.6 20.3 23.5 27.7 30.2 13.6 18.0 19.1 22.7 25.9 28.0 10.0
    Pancreas 9.4 7.6 8.4 8.4 10.8 1.4 8.8 7.3 8.4 8.1 10.3 1.5 10.1 8.1 8.5 8.7 11.5 1.4
    Larynx 59.7 62.3 66.3 72.9 75.5 15.8 60.2 62.8 66.9 73.2 75.9 15.7 55.4 57.8 58.9 67.6 69.9 14.5
    Lung 11.3 12.7 16.5 20.1 26.7 15.4 10.4 11.6 15.2 17.9 22.7 12.3 14.2 16.2 20.1 25.8 35.8 21.6
    Breast 77.9 83.2 88.6 91.1 92.3 14.4 75.1 85.6 87.2 89.9 87.1 12.0 78.0 83.2 88.6 91.1 92.3 14.3
    Cervix uteri 77.5 80.0 81.4 80.5 79.9 2.4 - - - - - - 77.5 80.0 81.4 80.5 79.9 2.4
    Corpus uteri 81.5 81.8 84.5 86.4 87.8 6.3 - - - - - - 81.5 81.8 84.5 86.4 87.8 6.3
    Ovary 58.7 58.9 61.8 61.1 64.1 5.4 - - - - - - 58.7 58.9 61.8 61.1 64.1 5.4
    Prostate 55.9 67.2 80.4 91.1 94.1 38.2 55.9 67.2 80.4 91.1 94.1 38.2 - - - - - -
    Testis 85.4 90.4 90.7 93.1 95.6 10.2 85.4 90.4 90.7 93.1 95.6 10.2 - - - - - -
    Kidney 62.0 66.1 73.6 78.4 82.2 20.2 60.8 64.4 73.0 78.2 81.6 20.8 64.5 69.7 74.7 78.8 83.6 19.1
    Bladder 69.1 73.1 75.7 76.7 75.8 6.7 70.0 74.8 77.5 78.8 77.8 7.8 65.5 66.3 68.8 68.6 67.7 2.2
    Brain and CNS 38.5 39.0 40.9 42.8 40.7 2.2 37.2 37.5 40.2 41.4 39.1 1.9 40.2 40.7 41.7 44.4 42.6 2.4
    Thyroid 94.2 94.9 98.4 99.9 100.3 6.1 87.2 89.5 96.0 100.1 100.6 13.4 95.4 95.9 98.7 99.9 100.2 4.8
    Hodgkin lymphoma 68.0 71.2 76.7 81.0 82.2 14.2 67.6 68.1 74.7 80.7 82.8 15.2 68.6 77.4 80.7 81.6 81.2 12.6
    Non-Hodgkin lymphoma 46.6 50.8 55.9 59.3 62.9 16.3 45.3 48.9 54.9 59.1 62.4 17.1 48.7 53.5 57.4 59.6 63.6 14.9
    Multiple myeloma 22.1 19.8 29.6 34.9 40.9 18.8 21.1 17.8 29.8 35.0 40.6 19.5 23.3 22.1 29.4 34.8 41.3 18.0
    Leukemia 26.5 33.3 42.0 47.6 51.0 24.5 26.2 32.3 41.8 46.8 51.1 24.9 26.8 34.6 42.2 48.6 50.8 24.0
    Other and ill defined 42.1 45.9 57.6 67.2 72.2 30.1 37.4 42.4 53.8 63.4 68.9 31.5 47.4 50.0 61.8 71.0 75.5 28.1
    Site/Type Crude prevalence rate per 100,000a)
    Age-standardized prevalence rate per 100,000b)
    Both sexes Men Women Both sexes Men Women
    All sites 3,162.8 2,781.0 3,544.1 1,956.9 1,826.6 2,171.5
    Lip, oral cavity, and pharynx 42.8 57.6 28.1 26.8 37.9 17.2
    Esophagus 18.0 32.5 3.6 10.3 20.6 1.8
    Stomach 504.4 668.9 340.1 291.5 425.6 180.9
    Colon and rectum 433.1 516.8 349.4 248.2 330.6 181.7
    Liver 120.3 180.2 60.4 73.5 116.8 34.2
    Gallbladderc) 38.2 39.1 37.3 21.1 24.7 18.4
    Pancreas 18.7 19.8 17.6 11.1 12.9 9.7
    Larynx 19.7 37.1 2.3 11.2 23.6 1.2
    Lung 137.2 172.8 101.8 78.7 110.2 54.5
    Breast 351.5 2.7 699.8 221.7 1.7 435.9
    Cervix uteri 99.1 - 198.0 61.5 - 120.0
    Corpus uteri 40.9 - 81.8 26.1 - 51.2
    Ovary 35.5 - 71.0 24.2 - 48.1
    Prostate 136.3 272.8 - 71.3 170.0 -
    Testis 5.8 11.5 - 5.2 10.3 -
    Kidney 69.3 93.7 45.0 43.5 62.0 27.1
    Bladder 61.6 100.6 22.7 33.7 64.1 10.6
    Brain and CNS 20.3 21.0 19.7 17.2 18.3 16.1
    Thyroid 696.8 236.3 1,156.8 464.9 160.2 767.5
    Hodgkin lymphoma 5.0 6.4 3.7 4.2 5.1 3.2
    Non-Hodgkin lymphoma 53.9 61.4 46.5 38.2 45.9 31.1
    Multiple myeloma 10.5 10.9 10.0 6.1 7.0 5.4
    Leukemia 37.8 41.8 33.8 35.2 39.2 31.1
    Other and ill defined 205.9 197.1 214.6 131.4 139.9 124.4
    Table 1. Cancer incidence, deaths and prevalence by sex in Korea, 2015

    CNS, central nervous system.

    Limited-duration prevalent cases on January 1, 2016. These are patients who were diagnosed between January 1, 1999 and December 31, 2015 and who were alive on January 1, 2016. Multiple primary cancer cases were counted multiple times,

    Include the gallbladder and other/unspecified parts of the biliary tract.

    Table 2. Crude and age-standardized cancer incidence rates by sex in Korea, 2015

    CNS, central nervous system.

    Age-adjusted using the Segi’s world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 3. The top 10 leading causes of death in Korea, 2015

    Source: Mortality Data, 2015, Statistics Korea [8].

    Age-adjusted using the Segi’s world standard population.

    Table 4. Crude and age-standardized cancer mortality rates by sex in Korea, 2015

    CNS, central nervous system.

    Age-adjusted using the world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 5. Trends in cancer incidence rates from 1999 to 2015 in Korea

    APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 6. Trends in cancer mortality rates from 1999 to 2015 in Korea

    APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 7. The five common sites/types of cancer incidence by age group and sex in Korea, 2015

    CNS, central nervous system.

    Table 8. Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2015 in Korea

    CNS, central nervous system.

    Percentage change in 5-year relative survival from 1993 to 1995 and 2011 to 2015,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 9. Crude and age-standardized rates of cancer prevalence by sex on January 1, 2016 in Korea

    CNS, central nervous system.

    Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2015 and who were alive on January 1, 2016. Multiple primary cancer cases were counted multiple times,

    Age-adjusted using the Segi’s world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP